Yi-Qian Nancy You, MD, MHSc, FACS

Peer-Reviewed Articles

1. Lapelusa, M, Qiao, W, Iorgulescu, B, San Lucas, FA, Patel, KP, Bhamidipati, D, Thomas, J, You, YN, Foo, WC, Maru, D, Thirumurthi, S, Morris, VK, Kopetz, S, Overman, MJ, Ludford, K. Long-Term Efficacy of Pembrolizumab and the Clinical Utility of ctDNA in Locally Advanced dMMR/MSI-H Solid Tumors. Nature communications 16(1), 2025. e-Pub 2025. PMID: 40374594.
2. Ng K, Eng C, Wildgoose P, You YN, Cercek A, Parikh A, Liska D, Ratti U, Stein BD. A blueprint for creating an early-onset colorectal cancer program based on experiences from 7 clinical centers across the United States and Canada. Oncologist 30(8), 2025. e-Pub 2025. PMID: 40747803.
3. Morris VK, Xiao W, Lin K, Wong CW, Wotman MT, Holliday EB, Huey RW, Noticewala SS, Ludmir EB, Bent AH, Ludford K, Messick C, Koay EJ, Smith G, Konishi T, Bednarski B, Chang GJ, Koong AC, You YN, Das P, Gillison ML. Time Dependency for Human Papillomavirus Circulating Tumor DNA Detection after Chemoradiation as a Prognostic Biomarker for Localized Anal Cancer. Clin Cancer Res 31(12):2399-2405, 2025. e-Pub 2025. PMID: 39873618.
4. Bhutiani, N, Yousef, M, Yousef, A, Haque, EU, Chang, GJ, Konishi, T, Bednarski, BK, You, YN, Shen, JY, Uppal, A. Does Extramural Vascular Invasion Predict Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer?. Clinical colorectal cancer 24(2):272-279.e2, 2025. e-Pub 2025. PMID: 40038019.
5. White, MG, Ayabe, RI, Zeineddine, MA, Zeineddine, F, Yousef, A, Yousef, M, Galbraith, NJ, Iorgulescu, JB, Scally, CP, Fournier, KF, Newhook, TE, You, YN, Willis, JA, Kopetz, S, Chang, GJ, Shen, JY, Uppal, A. Tumoral and circulating genomic landscape inform survival differences in colorectal carcinomatosis. Translational Oncology 55, 2025. e-Pub 2025. PMID: 40184716.
6. Bhutiani, N, Ochiai, K, Peacock, O, You, YN, Bednarski, BK, Messick, C, Skibber, JM, White, MG, Chang, GJ, Konishi, T, Uppal, A. Risk Factors for Regrowth After Nonoperative Management for Rectal Cancer. Annals of surgical oncology 32(5):3098-3105, 2025. e-Pub 2025. PMID: 39924589.
7. Sammour T, Peacock O, Bednarski BK, Dasari A, Das P, Johnson B, Smith GL, Chang GJ, Skibber J, You YN. Prospective longitudinal trajectory of cancer survivorship among patients with recurrent rectal cancer: impact of treatment modalities and resection status. Colorectal Dis 27(5):e70110, 2025. e-Pub 2025. PMID: 40371878.
8. Manisundaram N, Childers CP, Hu CY, Uppal A, Konishi T, Bednarski BK, White MG, Peacock O, You YN, Chang GJ. Rise in Minimally Invasive Surgery for Colorectal Cancer Is Associated With Adoption of Robotic Surgery. Dis Colon Rectum 68(4):426-436, 2025. e-Pub 2025. PMID: 39745312.
9. Alshenaifi JY, Vetere G, Maddalena G, Yousef M, White MG, Shen JP, Vilar E, Parseghian C, Dasari A, Morris VK, Huey R, Overman MJ, Wolff R, Raghav KP, Willis J, Alfaro K, Futreal A, You YN, Kopetz S. Mutational and co-mutational landscape of early onset colorectal cancer. Biomarkers 30(1):64-76, 2025. e-Pub 2025. PMID: 39761813.
10. Bhutiani N, Peacock O, Uppal A, Hu CY, Bednarski BK, Taggart MW, Dasari A, Morris VK, Kaur H, Kopetz S, Holliday EB, Das P, You YN, Chang GJ. The prognostic impact of tumor deposits in colorectal cancer: More than just N1c. Cancer 130(23):4052-4060, 2024. e-Pub 2024. PMID: 39306694.
11. Denu RA, Quintana-Perez CD, Wangsiricharoen S, Ingram DR, Wani KM, Lazar AJ, Ratan R, Roland CL, You YN. DNA Mismatch Repair Deficiency as a Biomarker in Sarcoma. Surg Oncol Insight 1(4), 2024. e-Pub 2024. PMID: 40190387.
12. Agnes, A, Nguyen, S, Konishi, T, Peacock, O, Bednarski, BK, You, YN, Messick, C, Tillman, MM, Skibber, JM, Chang, GJ, Uppal, A. Early Postoperative Prediction of Complications and Readmission After Colorectal Cancer Surgery Using an Artificial Neural Network. Diseases of the colon and rectum 67(10):1341-1352, 2024. e-Pub 2024. PMID: 38959458.
13. Bhutiani N, Ochiai K, Awiwi MO, Rodriguez-Bigas MA, Uppal A, Peacock O, Messick C, White MG, Skibber JM, Bednarski BK, You YN, Chang GJ, Kaur H, Konishi T. Para-aortic Lymph Node Dissection for Colorectal Cancer: Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes. Ann Surg Oncol 31(9):5962-5970, 2024. e-Pub 2024. PMID: 38836917.
14. DiBrito SR, Manisundaram N, Kim Y, Peacock O, Hu CY, Bednarski B, You YN, Uppal A, Tillman M, Konishi T, Kaur H, Palmquist S, Holliday E, Dasari A, Chang GJ. Perioperative and oncological outcomes following robotic en bloc multivisceral resection for colorectal cancer. Colorectal Dis 26(5):949-957, 2024. e-Pub 2024. PMID: 38576073.
15. Bolivar AM, Duzagac F, Deng N, Reyes-Uribe L, Chang K, Wu W, Bowen CM, Taggart MW, Thirumurthi S, Lynch PM, You YN, Rodriguez-Pascual J, Lipkin SM, Kopetz S, Scheet P, Lizee GA, Reuben A, Sinha KM, Vilar E. Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention. Gastroenterology 166(5):787-801.e11, 2024. e-Pub 2024. PMID: 38244726.
16. Cho D, Roth M, Peterson SK, Jennings K, Kim S, Weathers SP, Ahmed S, Livingston JA, Barcenas C, You YN, Milbury K. Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship: Protocol for a Measurement Burst Study. JMIR Res Protoc 13:e53307, 2024. e-Pub 2024. PMID: 38652520.
17. Maki H, Haddad A, Lendoire M, Newhook TE, Peacock O, Bednarski BK, Konishi T, Vauthey JN, You YN. Evolving survival gains in patients with young-onset colorectal cancer and synchronous resectable liver metastases. Eur J Surg Oncol 50(4):108057, 2024. e-Pub 2024. PMID: 38461567.
18. Baydogan S, Mohindroo C, Hasanov M, Montiel MF, Quesada P, Cazacu IM, Luzuriaga Chavez AA, Mork ME, Dong W, Feng L, You YN, Arun B, Vilar E, Brown P, Katz MHG, Chari ST, Maitra A, Tamm EP, Kim MP, Bhutani MS, McAllister F. New-onset diabetes is a predictive risk factor for pancreatic lesions in high-risk individuals: An observational cohort study. Endosc Ultrasound 13(2):83-88, 2024. e-Pub 2024. PMID: 38947744.
19. Agnes A, Peacock O, Manisundaram N, Kim Y, Stanietzky N, Vikram R, Bednarski BK, You YN, Konishi T, Chang GJ. The Learning Curve for Robotic Lateral Pelvic Lymph Node Dissection for Rectal Cancer: A View from the West. Dis Colon Rectum, 2024. e-Pub 2024. PMID: 38959454.
20. Hall WA, Li J, You YN, Gollub MJ, Grajo JR, Rosen M, dePrisco G, Yothers G, Dorth JA, Rahma OE, Russell MM, Gross HM, Jacobs SA, Faller BA, George S, Al Baghdadi T, Haddock MG, Valicenti R, Hong TS, George TJ. Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma. J Clin Oncol 41(29):4643-4651, 2023. e-Pub 2023. PMID: 37478389.
21. White MG, Damania A, Alshenaifi J, Sahasrabhojane P, Peacock O, Losh J, Wong MC, Lutter-Berkova Z, Chang GJ, Futreal A, Wargo JA, Ajami NJ, Kopetz S, You YN. Young-onset Rectal Cancer: Unique Tumoral Microbiome and Correlation With Response to Neoadjuvant Therapy. Ann Surg 278(4):538-548, 2023. e-Pub 2023. PMID: 37465976.
22. Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. Hepatectomy Before Primary Tumor Resection as the Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol 30(9):5403-5404, 2023. e-Pub 2023. PMID: 37358681.
23. Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol 30(9):5390-5400, 2023. e-Pub 2023. PMID: 37285096.
24. Peacock O, Manisundaram N, Kim Y, Konishi T, Stanietzky N, Vikram R, Bednarski BK, You YN, Chang GJ. Therapeutic lateral pelvic lymph node dissection in rectal cancer: When to dissect? Size is not everything. Br J Surg 110(8):985-986, 2023. e-Pub 2023. PMID: 37150892.
25. Rooney MK, De B, Corrigan K, Smith GL, Taniguchi C, Minsky BD, Ludmir EB, Koay EJ, Das P, Koong AC, Peacock O, Chang G, You YN, Morris VK, Nogueras-González G, Holliday EB. Patient-reported Bowel Function and Bowel-related Quality of Life After Pelvic Radiation for Rectal Adenocarcinoma: The Impact of Radiation Fractionation and Surgical Resection. Clin Colorectal Cancer 22(2):211-221, 2023. e-Pub 2023. PMID: 36878805.
26. Ludford K, Ho WJ, Thomas JV, Raghav KPS, Murphy MB, Fleming ND, Lee MS, Smaglo BG, You YN, Tillman MM, Kamiya-Matsuoka C, Thirumurthi S, Messick C, Johnson B, Vilar E, Dasari A, Shin S, Hernandez A, Yuan X, Yang H, Foo WC, Qiao W, Maru D, Kopetz S, Overman MJ. Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors. J Clin Oncol 41(12):JCO2201351, 2023. e-Pub 2023. PMID: 36623241.
27. You YN, Moskowitz JB, Chang GJ, Mork ME, Rodriguez-Bigas MA, Bednarski BK, Messick CA, Tillman MM, Skibber JM, Nguyen ST, Kopetz S, Vilar E. Germline Cancer Risk Profiles Of Young-Onset Colorectal Cancer Patients: Findings From A Prospective Universal Germline Testing and Tele-Genetics Program. Dis Colon Rectum 66(4):531-542, 2023. e-Pub 2023. PMID: 35195555.
28. Hernandez S, Das P, Holliday EB, Shen L, Lu W, Johnson B, Messick CA, Taniguchi CM, Skibber J, Ludmir EB, You YN, Smith GL, Bednarski B, Kostousov L, Koay EJ, Minsky BD, Tillman M, Portier S, Eng C, Koong AC, Chang GJ, Foo WC, Wang J, Soto LS, Morris VK. Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer. Cancers (Basel) 15(6), 2023. e-Pub 2023. PMID: 36980587.
29. Martin, AN, Tzeng, CD, Arvide, EM, Skibber, JM, Chang, GJ, You, YN, Bednarski, BK, Uppal, A, Dewhurst, WL, Cristo, JV, Chun, YS, Tran Cao, HS, Vauthey, JN, Newhook, TE. Impact of cumulative operative time on postoperative complication risk in simultaneous resections of colorectal liver metastases and primary tumors. HPB 25(3):347-352, 2023. e-Pub 2023. PMID: 36697350.
30. Santos DA, Zhang L, Do KA, Bednarski BK, Robinson Ledet C, Limmer A, Gibson H, You YN. Chemotherapy and Abdominal Wall Closure Technique Increase the Probability of Postoperative Ventral Incisional Hernia in Patients With Colon Cancer. Am Surg 89(1):31348211011149, 2023. e-Pub 2023. PMID: 33877925.
31. Del Carmen G, Reyes-Uribe L, Goyco D, Evans K, Bowen CM, Kinnison JL, Sepeda VO, Weber DM, Moskowitz J, Mork ME, Thirumurthi S, Lynch PM, Rodriguez-Bigas MA, Taggart MW, You YN, Vilar E. Colorectal surveillance outcomes from an institutional longitudinal cohort of lynch syndrome carriers. Front Oncol 13:1146825, 2023. e-Pub 2023. PMID: 37168379.
32. Goffredo, P, Khan, A, Mott, SL, Jensen, CC, Madoff, RD, Gaertner, WB, You, YN, Hassan, I. Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer. Annals of surgery 276(6):E819-E824, 2022. e-Pub 2022. PMID: 34353995.
33. Peacock O, Vilar E, Guraieb-Trueba M, Thirumurthi S, Chang GJ, You YN. Clinically Significant Metachronous Colorectal Pathology Detected Among Young-Onset Colorectal Cancer Survivors: Implications for Post-Resection Surveillance Guidelines. Gastroenterology 163(6):1682-1684.e2, 2022. e-Pub 2022. PMID: 35987446.
34. Peacock O, Manisundaram N, Dibrito SR, Kim Y, Hu CY, Bednarski BK, Konishi T, Stanietzky N, Vikram R, Kaur H, Taggart MW, Dasari A, Holliday EB, You YN, Chang GJ. Magnetic Resonance Imaging Directed Surgical Decision Making for Lateral Pelvic Lymph Node Dissection in Rectal Cancer after Total Neoadjuvant Therapy (TNT). Ann Surg 276(4):654-664, 2022. e-Pub 2022. PMID: 35837891.
35. De B, Corrigan KL, Rooney MK, Ludmir EB, Das P, Smith GL, Taniguchi CM, Minsky BD, Koay EJ, Koong A, Morris VK, Messick CA, You YN, Chang GJ, Westney OL, Nogueras Gonzalez GM, Holliday EB. Patient-reported bowel and urinary function in long-term survivors of squamous cell carcinoma of the anus treated with definitive intensity-modulated radiotherapy and concurrent chemotherapy. Int J Radiat Oncol Biol Phys 114(1):78-88, 2022. e-Pub 2022. PMID: 35589011.
36. Uppal A, Helmink B, Grotz TE, Konishi T, Fournier KF, Nguyen S, Taggart MW, Shen JP, Bednarski BK, You YN, Chang GJ. What is the Risk for Peritoneal Metastases and Survival Afterwards in T4 Colon Cancers?. Ann Surg Oncol 29(7):4224-4233, 2022. e-Pub 2022. PMID: 35307803.
37. DiPeri TP, Newhook TE, Day RW, Chiang YJ, Dewhurst WL, Arvide EM, Bruno ML, Scally CP, Roland CL, Katz MHG, Vauthey JN, Chang GJ, Badgwell BD, Perrier ND, Grubbs EG, Lee JE, Tzeng CD, Consortium P. A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients. Surg Open Sci 9:51-57, 2022. e-Pub 2022. PMID: 35663797.
38. Corrigan KL, Fu S, Chen YS, Kaiser K, Roth M, Peterson SK, Shih YT, Jagsi R, Giordano SH, Volk RJ, Yabroff KR, Banegas MP, Acquati C, Conti RM, Ma HY, Ku K, You YN, Smith GL. Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery. Cancer 128(13):2455-2462, 2022. e-Pub 2022. PMID: 35417565.
39. Rogers, JE, Woodard, TL, Nogueras Gonzalez, G, Dasari, NV, Johnson, B, Morris, VK, Kee, BK, Vilar Sanchez, E, You, YN, Chang, GJ, Bednarski, BK, Skibber, JM, Rodriguez-Bigas, MA, Eng, C. Colorectal cancer during pregnancy or postpartum. Obstetric Medicine 15(2):118-124, 2022. e-Pub 2022. PMID: 35845232.
40. Kothari, A, White, MG, Peacock, O, Kaur, H, Palmquist, SM, You, YN, Taggart, MW, Salem, UI, Overman, MJ, Kopetz, S, Chang, GJ. Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer. British Journal of Surgery 109(6):489-492, 2022. e-Pub 2022. PMID: 35576377.
41. O’Connell, LV, Zaborowski, AM, Abdile, A, Adamina, M, Aigner, F, D’Allens, L, Allmer, C, Álvarez, A, Anula, R, Andric, M, Bach, SS, Bala, M, Barussaud, M, Bausys, A, Beggs, A, Bellolio, F, Bennett, MR, Bevan, V, Biondo, S, Bislenghi, G, Bludau, M, Brown, C, Bruns, CJ, Buchanan, D, Buchwald, P, Burger, JW, Burlov, N, Campanelli, M, Capdepont, M, Carvello, M, Chew, HH, Christoforidis, D, Clark, D, Climent, M, Collinson, R, Cologne, KG, Contreras, T, Croner, R, Daniels, IR, Dapri, G, Davies, RJ, Delrio, P, Denost, Q, Deutsch, M, Dias, A, D'Hoore, A, Drozdov, E, Duek, D, Guren, M, You, YN. Post-Operative Functional Outcomes in Early Age Onset Rectal Cancer. Frontiers in Oncology 12, 2022. e-Pub 2022. PMID: 35707361.
42. Baxter NN, Kennedy EB, Bergsland E, Berlin J, George TJ, Gill S, Gold PJ, Hantel A, Jones L, Lieu C, Mahmoud N, Morris AM, Ruiz-Garcia E, You YN, Meyerhardt JA. Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update. J Clin Oncol 40(8):JCO2102538, 2022. e-Pub 2022. PMID: 34936379.
43. Tran CG, Goffredo P, Mott SL, Hart A, You YN, Vauthey JN, Weigel RJ, Hassan I. The impact of KRAS mutation, microsatellite instability, and tumor laterality on the prognosis of nonmetastatic colon cancer. Surgery 171(3):657-665, 2022. e-Pub 2022. PMID: 34865865.
44. Basen-Engquist, KM, Raber, M, Strong, LL, Schembre, S, Li, L, Arun, BK, Lu, KH, You, YN, Vilar Sanchez, E, Lynch, PM, Fares, S, Peterson, SK. Optimization of an mHealth lifestyle intervention for families with hereditary cancer syndromes. Contemporary Clinical Trials 113, 2022. e-Pub 2022. PMID: 34971795.
45. Holliday EB, Morris VK, Johnson B, Eng C, Ludmir EB, Das P, Minsky BD, Taniguchi C, Smith GL, Koay EJ, Koong AC, Delclos ME, Skibber JM, Rodriguez-Bigas MA, You YN, Bednarski BK, Tillman MM, Chang GJ, Jennings K, Messick CA. Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution. Oncologist 27(1):40-47, 2022. e-Pub 2022. PMID: 35305097.
46. Nofal S, You YN, Chang GJ, Grubbs EG, Bednarski B. Development of an Online Curriculum for Surgeons on the Use of Pelvic Magnetic Resonance Imaging in Rectal Cancer and Results of a Pilot Study. J Surg Res 270:279-285, 2022. e-Pub 2022. PMID: 34717261.
47. Swords DS, You YN. Understanding Factors That Mediate the Association Between Socioeconomic Status and Survival After Surgery for Locoregional Colon Cancer. Ann Surg Oncol 29(1):717-718, 2022. e-Pub 2022. PMID: 34467508.
48. You YN, Dasari A, Chang GJ. Report from American Society of Clinical Oncology Symposium 2020 and American Society of Clinical Oncology Gastrointestinal Cancer Symposium 2021. Dis Colon Rectum 65(1):8-10, 2022. e-Pub 2022. PMID: 34784317.
49. Swords DS, Bednarski BK, Messick CA, Tillman MM, Chang GJ, You YN. Quality and Location of the Surgical Episode Mediate a Large Proportion of Socioeconomic-Based Survival Disparities in Patients with Resected Stage I-III Colon Cancer. Ann Surg Oncol 29(1):706-716, 2022. e-Pub 2022. PMID: 34406541.
50. Rahma OE, Yothers G, Hong TS, Russell MM, You YN, Parker W, Jacobs SA, Colangelo LH, Lucas PC, Gollub MJ, Hall WA, Kachnic LA, Vijayvergia N, O'Rourke MA, Faller BA, Valicenti RK, Schefter TE, Moxley KM, Kainthla R, Stella PJ, Sigurdson E, Wolmark N, George TJ. Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial. JAMA Oncol 7(8):1225-1230, 2021. e-Pub 2021. PMID: 34196693.
51. Hester R, Advani S, Rashid A, Holliday E, Messick C, Das P, You YN, Taniguchi C, Brian Bednarski EJK, Rodriguez-Bigas M, Skibber J, Wolff R, Chang G, Minsky BD, Foo WC, K Morris NRV, Eng C. CEA as a blood-based biomarker in anal cancer. Oncotrget 12(11):1037-1045, 2021. e-Pub 2021. PMID: 34084278.
52. Reyes-Uribe L, Wu W, Gelincik O, Bommi PV, Francisco-Cruz A, Solis LM, Lynch PM, Lim R, Stoffel EM, Kanth P, Samadder NJ, Mork ME, Taggart MW, Milne GL, Marnett LJ, Vornik L, Liu DD, Revuelta M, Chang K, You YN, Kopelovich L, Wistuba II, Lee JJ, Sei S, Shoemaker RH, Szabo E, Richmond E, Umar A, Perloff M, Brown PH, Lipkin SM, Vilar E. Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa. Gut 70(3):555-566, 2021. e-Pub 2021. PMID: 32641470.
53. Malakorn S, Ouchi A, Hu CY, Sandhu L, Dasari A, You YN, Kopetz ES, Ellis LM, Chang GJ. Tumor Sidedness, Recurrence, and Survival After Curative Resection of Localized Colon Cancer. Clin Colorectal Cancer 20(1):e53-e60, 2021. e-Pub 2021. PMID: 33004292.
54. Dos Anjos Jácome, AA, Vreeland, TJ, Johnson, B, Kawaguchi, Y, Wei, SH, You, YN, Vilar Sanchez, E, Vauthey, JN, Eng, C. The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients. British journal of cancer 124(4):797-804, 2021. e-Pub 2021. PMID: 33208919.
55. De Bellis M, Vega EA, Kawaguchi Y, Panettieri E, Velasco JD, Vreeland TJ, You YN, Holmes AA, Mehran RJ, Vauthey JN. Simultaneous Sigmoid Colectomy, Bilobar Liver Resection and Lung Metastasectomy via a Transdiaphragmatic Approach for Stage IV Colonic Adenocarcinoma. Ann Surg Oncol 28(2):863-864, 2021. e-Pub 2021. PMID: 32813205.
56. Peacock O, Limvorapitak T, Bednarski BK, Kaur H, Taggart MW, Dasari A, Holliday EB, Minsky BD, You YN, Chang GJ. Robotic lateral pelvic lymph node dissection after chemoradiation for rectal cancer: a Western perspective. Colorectal Dis 22(12):2049-2056, 2020. e-Pub 2020. PMID: 32892473.
57. Peacock O, Limvorapitak T, Hu CY, Bednarski BK, Tillman MM, Kaur H, Taggart MW, Dasari A, Holliday EB, You YN, Chang GJ. Robotic rectal cancer surgery: comparative study of the impact of obesity on early outcomes. Br J Surg 107(12):1552-1557, 2020. e-Pub 2020. PMID: 32996597.
58. Zafar SN, Hu CY, Snyder RA, Cuddy A, You YN, Lowenstein LM, Volk RJ, Chang GJ. Predicting Risk of Recurrence After Colorectal Cancer Surgery in the United States: An Analysis of a Special Commission on Cancer National Study. Ann Surg Oncol 27(8):2740-2749, 2020. e-Pub 2020. PMID: 32080809.
59. Heald B, Hampel H, Church J, Dudley B, Hall MJ, Mork ME, Singh A, Stoffel E, Stoll J, You YN, Yurgelun MB, Kupfer SS, Gastrointestinal Cancer CGOTAOI. Collaborative Group of the Americas on Inherited Gastrointestinal Cancer Position statement on multigene panel testing for patients with colorectal cancer and/or polyposis. Fam Cancer 19(3):223-239, 2020. e-Pub 2020. PMID: 32172433.
60. Toomey S, Gunther J, Carr A, Weksberg DC, Thomas V, Salvucci M, Bacon O, Sherif EM, Fay J, Kay EW, Sheehan KM, McNamara DA, Sanders KL, Mathew G, Breathnach OS, Grogan L, Morris PG, Foo WC, You YN, Prehn JH, O'Neill B, Krishnan S, Hennessy BT, Furney SJ. Genomic and Transcriptomic Characterization of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Cancers (Basel) 12(7), 2020. e-Pub 2020. PMID: 32640573.
61. Patel SH, Hu CY, Massarweh NN, You YN, McCabe R, Dietz D, Facktor MA, Chang GJ. Circumferential Resection Margin as a Hospital Quality Assessment Tool for Rectal Cancer Surgery. J Am Coll Surg 230(6):1008-1018.e5, 2020. e-Pub 2020. PMID: 32142927.
62. Goffredo P, Zhou P, Ginader T, Hrabe J, Gribovskaja-Rupp I, Kapadia M, You YN, Hassan I. Positive circumferential resection margins following locally advanced colon cancer surgery: Risk factors and survival impact. J Surg Oncol 121(3):538-546, 2020. e-Pub 2020. PMID: 31853986.
63. Nofal S, You YN, Chang GJ, Grubbs EE, Bednarski BK. Residents entering Complex General Surgical Oncology fellowship lack confidence with pelvic MRI for rectal cancer: Results of a needs assessment survey. Am J Surg 219(2):304-308, 2020. e-Pub 2020. PMID: 31753316.
64. You YN, Lee LD, Deschner BW, Shibata D. Colorectal Cancer in the Adolescent and Young Adult Population. JCO Oncol Pract 16(1):19-27, 2020. e-Pub 2020. PMID: 32039664.
65. Sammour T, Malakorn S, Thampy R, Kaur H, Bednarski BK, Messick CA, Taggart M, Chang GJ, You YN. Selective central vascular ligation (D3 lymphadenectomy) in patients undergoing minimally invasive complete mesocolic excision for colon cancer: optimizing the risk benefit equation. Colorectal Dis 22(1):53-61, 2020. e-Pub 2020. PMID: 31356721.
66. Donato KM, Moore K, Parker WM, Peterson SK, Gritz ER, Amos CI, Lu KH, Lynch PM, Rodriguez-Bigas MA, You YN, Burton-Chase AM. Health and lifestyle behaviors in colorectal cancer survivors with and without Lynch syndrome. J Community Genet 11(1):59-63, 2020. e-Pub 2020. PMID: 31016603.
67. Berkman AM, Livingston JA, Merriman K, Hildebrandt M, Wang J, Dibaj S, McQuade J, You YN, Ying A, Barcenas C, Bodurka D, DePombo A, Lee HJ, deGroot J, Roth M. Long-term survival among 5-year survivors of adolescent and young adult cancer. Cancer 126(16):3708-3718, 2020. e-Pub 2020.
68. Omark J, Vilar E, You YN, Dunnington L, Noblin S, Stevens B, Mork M. Patients with unexplained mismatch repair deficiency are interested in updated genetic testing. Hered Cancer Clin Pract 18:19, 2020. e-Pub 2020. PMID: 32973963.
69. Chang GJ, You YN, Russell CA, Tierno MB, Turner M, Bennett JP, Lau A, Hochster HS. Young-Onset Colon Cancer and Recurrence Risk By Gene Expression. J Natl Cancer Inst, 2020. e-Pub 2020. PMID: 32040172.
70. Malakorn S, Yang Y, Bednarski BK, Kaur H, You YN, Holliday EB, Dasari A, Skibber JM, Rodriguez-Bigas MA, Chang GJ. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?. Dis Colon Rectum 62(10):1158-1166, 2019. e-Pub 2019. PMID: 31490825.
71. Bednarski BK, Nickerson TP, You YN, Messick CA, Speer B, Gottumukkala V, Manandhar M, Weldon M, Dean EM, Qiao W, Wang X, Chang GJ. Randomized clinical trial of accelerated enhanced recovery after minimally invasive colorectal cancer surgery (RecoverMI trial). Br J Surg 106(10):1311-1318, 2019. e-Pub 2019. PMID: 31216065.
72. Lowenstein LM, Volk RJ, Cuddy A, Hempstead AP, You YN, Van Loon K, Millas S, Meyerhardt JA, Gavin P, Chang GJ. Patients' information needs and attitudes about post-treatment surveillance for colorectal cancer in the United States: a multi-perspective, mixed methods study. BMJ Open 9(8):e025888, 2019. e-Pub 2019. PMID: 31420381.
73. Yang Y, Malakorn S, Maldonado K, Bednarski BK, Kiernan CM, Thirumurthi S, Chang GJ, You YN. The Pelvis-First Approach for Robotic Proctectomy in Patients with Redundant Abdominal Colon. Ann Surg Oncol 26(8):2514-2515, 2019. e-Pub 2019. PMID: 31102088.
74. Lee JH, Emelogu I, Kukreja K, Ali FS, Nogueras-Gonzalez G, Lum P, Coronel E, Ross W, Raju GS, Lynch P, Thirumurthi S, Stroehlein J, Wang Y, You YN, Weston B. Safety and efficacy of metal stents for malignant colonic obstruction in patients treated with bevacizumab. Gastrointest Endosc 90(1):116-124, 2019. e-Pub 2019. PMID: 30797835.
75. Mork ME, Rodriguez A, Bannon SA, Lynch PM, Rodriguez-Bigas MA, Thirumurthi S, You YN, Vilar E. Outcomes of disease-specific next-generation sequencing gene panel testing in adolescents and young adults with colorectal cancer. Cancer Genet 235-236:77-83, 2019. e-Pub 2019. PMID: 31101557.
76. Lieu C, Kennedy EB, Bergsland E, Berlin J, George TJ, Gill S, Gold PJ, Hantel A, Jones L, Mahmoud N, Meyerhardt J, Morris AM, Ruíz-García E, You YN, Baxter N. Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline. J Clin Oncol 37(16):1436-1447, 2019. e-Pub 2019. PMID: 30986117.
77. You YN, Borras E, Chang K, Price BA, Mork M, Chang GJ, Rodriguez-Bigas MA, Bednarski BK, Meric-Bernstam F, Vilar E. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine. Dis Colon Rectum 62(4):429-437, 2019. e-Pub 2019. PMID: 30730459.
78. Malakorn S, Stein SL, Lee JH, You YN. Urgent Management of Obstructing Colorectal Cancer: Divert, Stent, or Resect?. J Gastrointest Surg 23(2):425-432, 2019. e-Pub 2019. PMID: 30284201.
79. Lillemoe HA, Kawaguchi Y, Passot G, Karagkounis G, Simoneau E, You YN, Mehran RJ, Chun YS, Tzeng CD, Aloia TA, Vauthey JN. Surgical Resection for Recurrence After Two-Stage Hepatectomy for Colorectal Liver Metastases Is Feasible, Is Safe, and Improves Survival. J Gastrointest Surg 23(1):84-92, 2019. e-Pub 2019. PMID: 30084064.
80. Dashti SG, Win AK, Hardikar SS, Glombicki SE, Mallenahalli S, Thirumurthi S, Peterson SK, You YN, Buchanan DD, Figueiredo JC, Campbell PT, Gallinger S, Newcomb PA, Potter JD, Lindor NM, Le Marchand L, Haile RW, Hopper JL, Jenkins MA, Basen-Engquist KM, Lynch PM, Pande M. Physical activity and the risk of colorectal cancer in Lynch syndrome. Int J Cancer 143(9):2250-2260, 2018. e-Pub 2018. PMID: 29904935.
81. Jensen G, Tao R, Eng C, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Koay E, Taniguchi C, Krishnan S, Das P. Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation. Adv Radiat Oncol 3(4):595-600, 2018. e-Pub 2018. PMID: 30370360.
82. Chang K, Taggart MW, Reyes-Uribe L, Borras E, Riquelme E, Barnett RM, Leoni G, San Lucas FA, Catanese MT, Mori F, Diodoro MG, You YN, Hawk ET, Roszik J, Scheet P, Kopetz S, Nicosia A, Scarselli E, Lynch PM, McAllister F, Vilar E. Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome. JAMA Oncol 4(8):1085-1092, 2018. e-Pub 2018. PMID: 29710228.
83. Osborne EM, Eng C, Skibber JM, Rodriguez-Bigas MA, Chang GJ, You YN, Bednarski BK, Minsky BD, Delclos ME, Koay E, Krishnan S, Crane CH, Das P. Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive Chemoradiation. Am J Clin Oncol 41(7):632-637, 2018. e-Pub 2018. PMID: 27755060.
84. Deshmukh AA, Zhao H, Das P, Chiao EY, You YN, Franzini L, Lairson DR, Swartz MD, Giordano SH, Cantor SB. Clinical and Economic Evaluation of Treatment Strategies for T1N0 Anal Canal Cancer. Am J Clin Oncol 41(7):626-631, 2018. e-Pub 2018. PMID: 27755059.
85. Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, Van Loon K, You YN, Kozower BD, Greenberg CC, Schrag D, Venook A, McKellar D, Winchester DP, Chang GJ, Working Group AFCTIONCSO. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer. JAMA 319(20):2104-2115, 2018. e-Pub 2018. PMID: 29800181.
86. Ikoma N, Roland CL, Cormier JN, Chiang YJ, Torres KE, Hunt KK, You YN, Feig BW. Nongastrointestinal Stromal Tumor Spindle Cell Sarcomas of the Colon or Rectum. Am Surg 84(4):570-575, 2018. e-Pub 2018. PMID: 29712608.
87. Sammour T, Malakorn S, Bednarski BK, Kaur H, Shin US, Messick C, You YN, Chang GJ. Oncological Outcomes After Robotic Proctectomy for Rectal Cancer: Analysis of a Prospective Database. Ann Surg 267(3):521-526, 2018. e-Pub 2018. PMID: 27997470.
88. Bednarski BK, Slack RS, Katz M, You YN, Papadopolous J, Rodriguez-Bigas MA, Skibber JM, Matin SF, Chang GJ. Assessment of Ileostomy Output Using Telemedicine: A Feasibility Trial. Dis Colon Rectum 61(1):77-83, 2018. e-Pub 2018. PMID: 29215474.
89. Ikoma N, Cloyd J, Badgwell BD, Agnes A, Rodriguez-Bigas M, Ajani JA, You YN. Clinical features and survival of gastric cancer patients with DNA mismatch repair deficiency. J Surg Oncol 117(4):707-709, 2018. e-Pub 2018. PMID: 29228462.
90. Holliday EB, Hunt A, You YN, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Bednarski BK, Eng C, Koay EJ, Minsky BD, Taniguchi C, Krishnan S, Herman JM, Das P. Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma. J Gastrointest Oncol 8(6):990-997, 2017. e-Pub 2017. PMID: 29299359.
91. Conrad C, Vauthey JN, Masayuki O, Sheth RA, Yamashita S, Passot G, Bailey CE, Zorzi D, Kopetz S, Aloia TA, You YN. Individualized Treatment Sequencing Selection Contributes to Optimized Survival in Patients with Rectal Cancer and Synchronous Liver Metastases. Ann Surg Oncol 24(13):3857-3864, 2017. e-Pub 2017. PMID: 28929463.
92. Cloyd JM, Katz MHG, Wang H, Cuddy A, You YN. Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Patients With Pancreatic Ductal Adenocarcinoma. JAMA Surg 152(11):1086-1088, 2017. e-Pub 2017. PMID: 28793134.
93. Gausachs M, Borras E, Chang K, Gonzalez S, Azuara D, Delgado Amador A, Lopez-Doriga A, San Lucas FA, Sanjuan X, Paules MJ, Taggart MW, Davies GE, Ehli EA, Fowler J, Moreno V, Pineda M, You YN, Lynch PM, Lazaro C, Navin NE, Scheet PA, Hawk ET, Capella G, Vilar E. Mutational Heterogeneity in APC and KRAS Arises at the Crypt level and Leads to Polyclonality in Early Colorectal Tumorigenesis. Clin Cancer Res 23(19):5936-5947, 2017. e-Pub 2017. PMID: 28645942.
94. Borras E, Chang K, Pande M, Cuddy A, Bosch JL, Bannon SA, Mork ME, Rodriguez-Bigas MA, Taggart MW, Lynch PM, You YN, Vilar E. In Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular Validation. Cancer Prev Res (Phila) 10(10):580-587, 2017. e-Pub 2017. PMID: 28765196.
95. You YN, Shiozaki H, Lee JE, Passot G, Goumard C, Okuno M, Aloia TA, Eng C, Chang G, Vauthey JN, Conrad C. Total Laparoscopic Management for Stage IV Colorectal Cancer Requiring Multivisceral Resection. Ann Surg Oncol 24(9):2595, 2017. e-Pub 2017. PMID: 28510798.
96. Goldstein JB, Wu W, Borras E, Masand G, Cuddy A, Mork ME, Bannon SA, Lynch PM, Rodriguez-Bigas M, Taggart MW, Wu J, Scheet P, Kopetz S, You YN, Vilar E. Can Microsatellite Status of Colorectal Cancer be Reliably Assessed after Neoadjuvant Therapy?. Clin Cancer Res 23(17):5246-5254, 2017. e-Pub 2017. PMID: 28522602.
97. Ikoma N, You YN, Bednarski BK, Rodriguez-Bigas MA, Eng C, Das P, Kopetz S, Messick C, Skibber JM, Chang GJ. Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer. J Clin Oncol 35(23):JCO2016721464, 2017. e-Pub 2017. PMID: 28657814.
98. Mork ME, Rodriguez A, Taggart MW, Rodriguez-Bigas MA, Lynch PM, Bannon SA, You YN, Vilar E. Identification of MSH2 inversion of exons 1-7 in clinical evaluation of families with suspected Lynch syndrome. Fam Cancer 16(3):357-361, 2017. e-Pub 2017. PMID: 28004223.
99. Malakorn S, Sammour T, Bednarski B, You YN, Chang GJ. Three Different Approaches to the Inferior Mesenteric Artery during Robotic D3 Lymphadenectomy for Rectal Cancer. Ann Surg Oncol 24(7):1923, 2017. e-Pub 2017. PMID: 28213788.
100. Price BA, Bednarski BK, You YN, Manandhar M, Dean EM, Alawadi ZM, Bryce Speer B, Gottumukkala V, Weldon M, Massey RL, Wang X, Qiao W, Chang GJ. Accelerated enhanced Recovery following Minimally Invasive colorectal cancer surgery (RecoverMI): a study protocol for a novel randomised controlled trial. BMJ Open 7(7):e015960, 2017. e-Pub 2017. PMID: 28729319.
101. Gunther JR, Chadha AS, Shin US, Park IJ, Kattepogu KV, Grant JD, Weksberg DC, Eng C, Kopetz SE, Das P, Delclos ME, Kaur H, Maru DM, Skibber JM, Rodriguez-Bigas MA, You YN, Krishnan S, Chang GJ. Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis. Adv Radiat Oncol 2(3):455-464, 2017. e-Pub 2017. PMID: 29114614.
102. Park IJ, You YN, Skibber JM, Rodriguez-Bigas MA, Das P, Eng C, Kopetz S, Wolff RA, Crane CH, Krishnan S, Minsky B, Hu CY, Nguyen S, Chang GJ. Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy. Am J Clin Oncol 40(3):277-282, 2017. e-Pub 2017. PMID: 27028350.
103. Sturgeon JD, Crane CH, Krishnan S, Minsky BD, Skibber JM, Rodriguez-Bigas MA, Chang GJ, You YN, Eng C, Das P. Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum. Am J Clin Oncol 40(2):163-166, 2017. e-Pub 2017. PMID: 25222072.
104. Alawadi Z, Phatak UR, Hu CY, Bailey CE, You YN, Kao LS, Massarweh NN, Feig BW, Rodriguez-Bigas MA, Skibber JM, Chang GJ. Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer. Cancer 123(7):1124-1133, 2017. e-Pub 2017. PMID: 27479827.
105. Burton-Chase AM, Parker WM, Polivka KM, Gritz ER, Amos CI, Lu KH, Lynch PM, Rodriguez-Bigas MA, You YN, Peterson SK. A comparison between Lynch syndrome and sporadic colorectal cancer survivors’ satisfaction with their health care providers. Cancer Medicine 6(3):698–707, 2017. e-Pub 2017.
106. Herzig DO, Buie WD, Weiser MR, You YN, Rafferty JF, Feingold D, Steele SR. Clinical Practice Guidelines for the Surgical Treatment of Patients With Lynch Syndrome. Dis Colon Rectum 60(2):137-143, 2017. e-Pub 2017. PMID: 28059909.
107. Tao R, Tsai CJ, Jensen G, Eng C, Kopetz S, Overman MJ, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Delclos ME, Koay E, Krishnan S, Crane CH, Das P. Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity. Radiother Oncol 122(1):146-151, 2017. e-Pub 2017. PMID: 28057329.
108. Mork ME, Borras E, Taggart MW, Cuddy A, Bannon SA, You YN, Lynch PM, Ramirez PT, Rodriguez-Bigas MA, Vilar E. Identification of a Novel PMS2 Alteration c.505C>G (R169G) In Trans with a PMS2 Pathogenic Mutation in a Patient with Constitutional Mismatch Repair Deficiency. Fam Cancer 15(4):587-91, 2016. e-Pub 2016. PMID: 27017610.
109. de Rosa N, Rodriguez-Bigas MA, Chang GJ, Veerapong J, Borras E, Krishnan S, Bednarski B, Messick CA, Skibber JM, Feig BW, Lynch PM, Vilar E, You YN. DNA Mismatch Repair Deficiency In Rectal Cancer: Benchmarking Its Impact On Prognosis, Neoadjuvant Response Prediction, And Clinical Cancer Genetics. J Clin Oncol 34(25):3039-46, 2016. e-Pub 2016. PMID: 27432916.
110. Borras E, San Lucas FA, Chang K, Zhou R, Masand G, Fowler J, Mork ME, You YN, Taggart MW, McAllister F, Jones DA, Davies GE, Edelmann W, Ehli EA, Lynch PM, Hawk ET, Capella G, Scheet P, Vilar E. Genomic Landscape of Colorectal Mucosa and Adenomas. Cancer Prev Res (Phila) 9(6):417-27, 2016. e-Pub 2016. PMID: 27221540.
111. You YN, Skibber JM, Hu CY, Crane CH, Das P, Kopetz ES, Eng C, Feig BW, Rodriguez-Bigas MA, Chang GJ. Impact of multimodal therapy in locally recurrent rectal cancer. Br J Surg 103(6):753-762, 2016. e-Pub 2016. PMID: 26933792.
112. Van Loon K, You YN, Hu CY, Francescatti AB, Greenberg CC, Venook AP, Schrag D, Chang GJ. How clinicians make decisions regarding surveillance and treatment of colorectal cancer (CRC) patients. J Clin Oncol 34(3_suppl):263, 2016. e-Pub 2016. PMID: 28151232.
113. Mork ME, You YN, Ying J, Bannon SA, Lynch PM, Rodriguez-Bigas MA, Vilar E. High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer. J Clin Oncol 33(31):3544-9, 2015. e-Pub 2015. PMID: 26195711.
114. Massarweh NN, Haynes AB, Chiang YJ, Chang GJ, You YN, Feig BW, Cormier JN. Adequacy of the National Quality Forum's Colon Cancer Adjuvant Chemotherapy Quality Metric: Is 4 Months Soon Enough?. Ann Surg 262(2):312-20, 2015. e-Pub 2015. PMID: 25185467.
115. Dineen S, Lynch PM, Rodriguez-Bigas MA, Bannon S, Taggart M, Reeves C, Modaro C, Overman M, Chang GJ, Skibber JM, You YN. A Prospective Six-Sigma Quality Improvement Trial To Optimize Universal Screening For Genetic Syndrome Among Patients with Young-Onset Colorectal Cancer. J Natl Compr Canc Netw 13(7):865-72, 2015. e-Pub 2015. PMID: 26150580.
116. Dempsey KM, Broaddus R, You YN, Noblin SJ, Mork M, Fellman B, Urbauer D, Daniels M, Lu K. Is it all Lynch syndrome?: An assessment of family history in individuals with mismatch repair-deficient tumors. Genet Med 17(6):476-84, 2015. e-Pub 2015. PMID: 25341111.
117. Martin LW, Veeramachaneni NK, Katz MH, You YN, Boughey JC, Nelson H, Hunt KK. New manual for cancer surgery issued: Operative Standards for Cancer Surgery. Bull Am Coll Surg 100(6):43-4, 2015. e-Pub 2015. PMID: 26182523.
118. Kneuertz PJ, Chang GJ, Hu CY, Rodriguez-Bigas MA, Eng C, Vilar E, Skibber JM, Feig BW, Cormier JN, You YN. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. JAMA Surg 150(5):402-9, 2015. e-Pub 2015. PMID: 25806815.
119. Altorki N, Kohman LJ, Veit LJ, You YN, Boughey JC. Limited resection as a cure for early lung cancer: time to challenge the gold standard?. Bull Am Coll Surg 100(5):57-8, 2015. e-Pub 2015. PMID: 26031124.
120. Bailey CE, Hu CY, You YN, Kaur H, Ernst RD, Chang GJ. Variation in positron emission tomography use after colon cancer resection. J Oncol Pract 11(3):e363-72, 2015. e-Pub 2015. PMID: 25852143.
121. Weiser MR, Fichera A, Schrag D, Boughey JC, You YN. Progress in the PROSPECT trial: precision treatment for rectal cancer?. Bull Am Coll Surg 100(4):51-2, 2015. e-Pub 2015. PMID: 25939207.
122. Hu CY, Bailey CE, You YN, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ. Time trend analysis of primary tumor resection for stage IV colorectal cancer: less surgery, improved survival. JAMA Surg 150(3):245-51, 2015. e-Pub 2015. PMID: 25588105.
123. Bailey CE, Tran Cao HS, Hu CY, Chang GJ, Feig BW, Rodriguez-Bigas MA, Nguyen ST, Skibber JM, You YN. Functional Deficits and Symptoms of Long-Term Survivors of Colorectal Cancer Treated by Multimodality Therapy Differ by Age at Diagnosis. J Gastrointest Surg 19(1):180-8, 2015. e-Pub 2015. PMID: 25213581.
124. Bailey CE, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ. Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010. JAMA Surg 150(1):1-6, 2015. e-Pub 2015. PMID: 25372703.
125. Eng C, Chang GJ, You YN, Das P, Rodriguez-Bigas M, Xing Y, Vauthey JN, Rogers JE, Ohinata A, Pathak P, Sethi S, Phillips JK, Crane CH, Wolff RA. The Role of Systemic Chemotherapy and Multidisciplinary Management in Improving the Overall Survival of Patients with Metastatic Squamous Cell Carcinoma of the Anal Canal. Oncotarget 5(22):11133-42, 2014. e-Pub 2014. PMID: 25373735.
126. Vilar E, Mork ME, Cuddy A, Borras E, Bannon SA, Taggart MW, Ying J, Broaddus RR, Luthra R, Rodriguez-Bigas MA, Lynch PM, You YQ. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer. Cancer Genet 207(10-12):495-502, 2014. e-Pub 2014. PMID: 25432668.
127. Massarweh NN, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Cormier JN, Feig BW, Chang GJ. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol 32(27):2967-74, 2014. e-Pub 2014. PMID: 25092785.
128. Massarweh NN, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Cormier JN, Feig BW, Chang GJ. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol 32(27):2967-74, 2014. e-Pub 2014. PMID: 25513452.
129. Hyngstrom JR, Tzeng CW, Beddar S, Das P, Krishnan S, Delclos ME, Crane CH, Chang GJ, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MA. Intraoperative Radiation Therapy for Locally Advanced Primary and Recurrent Colorectal Cancer: Ten-year Institutional Experience. J Surg Oncol 109(7):652-8, 2014. e-Pub 2014. PMID: 24510523.
130. Hallemeier CL, You YN, Larson DW, Dozois EJ, Nelson H, Klein KA, Miller RC, Haddock MG. Multimodality Therapy including Salvage Surgical Resection and Intraoperative Radiotherapy for Patients with Squamous-Cell Carcinoma of the Anus with Residual or Recurrent Disease after Primary Chemoradiotherapy. Dis Colon Rectum 57(4):442-8, 2014. e-Pub 2014. PMID: 24608300.
131. Haynes AB, You YN, Hu CY, Eng C, Kopetz ES, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ. Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007. Cancer 120(8):1162-70, 2014. e-Pub 2014. PMID: 24474245.
132. Massarweh NN, Chiang YJ, Xing Y, Chang GJ, Haynes AB, You YN, Feig BW, Cormier JN. Association Between Travel Distance and Metastatic Disease at Diagnosis Among Patients with Colon Cancer. J Clin Oncol 32(9):942-8, 2014. e-Pub 2014. PMID: 24516014.
133. Das P, Eng C, Rodriguez-Bigas MA, Chang GJ, Skibber JM, You YN, Maru DM, Munsell MF, Clemons MV, Kopetz SE, Garrett CR, Shureiqi I, Delclos ME, Krishnan S, Crane CH. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial. Int J Radiat Oncol Biol Phys 88(2):301-5, 2014. e-Pub 2014. PMID: 24315563.
134. Phatak UR, Kao LS, You YQ, Rodriguez-Bigas MA, Skibber JM, Feig BW, Nguyen S, Cantor SB, Chang GJ. Impact of ileostomy-related complications on the multidisciplinary treatment of rectal cancer. Ann Surg Oncol 21(2):507-12, 2014. e-Pub 2014. PMID: 24085329.
135. Ahnen DJ, Wade SW, Jones WF, Sifri R, Mendoza Silveiras J, Greenamyer J, Guiffre S, Axilbund J, Spiegel A, You YN. The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin Proc 89(2):216-24, 2014. e-Pub 2014. PMID: 24393412.
136. Roses RE, Tzeng CW, Ross MI, Fournier KF, Abbott DE, You YN. The palliative index: predicting outcomes of emergent surgery in patients with cancer. J Palliat Med 17(1):37-42, 2014. e-Pub 2014. PMID: 24410420.
137. Bannon SA, Mork M, Vilar E, Peterson SK, Lu K, Lynch PM, Rodriguez-Bigas MA, You YN. Patient-reported disease knowledge and educational needs in Lynch syndrome: findings of an interactive multidisciplinary patient conference. Hered Cancer Clin Pract 12(1):1, 2014. e-Pub 2014. PMID: 24499499.
138. Agarwal A, Chang GJ, Hu CY, Taggart M, Rashid A, Park IJ, You YN, Das P, Krishnan S, Crane CH, Rodriguez-Bigas M, Skibber J, Ellis L, Eng C, Kopetz S, Maru DM. Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy. Cancer 119(24):4231-41, 2013. e-Pub 2013. PMID: 24089344.
139. Wisniewski WR, Fournier KF, Ling YK, Slack RS, Babiera G, Grubbs EG, Moore LJ, Fleming JB, You YN. A focused curriculum in surgical oncology for the third-year medical students. J Surg Res 185(2):555-60, 2013. e-Pub 2013. PMID: 23845865.
140. Eng C, Chang GJ, You YN, Das P, Xing Y, Delclos M, Wolff RA, Rodriguez-Bigas MA, Skibber J, Ohinata A, Gould S, Phillips J, Crane CH. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal. Cancer 119(21):3769-75, 2013. e-Pub 2013. PMID: 24037775.
141. Russell MC, You YN, Hu CY, Cormier JN, Feig BW, Skibber JM, Rodriguez-Bigas MA, Nelson H, Chang GJ. A novel risk-adjusted nomogram for rectal cancer surgery outcomes. JAMA Surg 148(8):769-77, 2013. e-Pub 2013. PMID: 23803722.
142. Bowles TL, Hu CY, You YN, Skibber JM, Rodriguez-Bigas MA, Chang GJ. An Individualized Conditional Survival Calculator for Patients with Rectal Cancer. Diseases of Colon and Rectum 56(5):551-9, 2013. e-Pub 2013. PMID: 23575393.
143. Boland GM, Chang GJ, Haynes AB, Chiang YJ, Chagpar R, Xing Y, Hu CY, Feig BW, You YN, Cormier JN. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer. Cancer 119(8):1593-601, 2013. e-Pub 2013. PMID: 23280510.
144. Chagpar R, Chiang YJ, Xing Y, Cormier JN, Feig BW, Rashid A, Chang GJ, You YN. Neuroendocrine tumors of the colon and rectum: prognostic relevance and comparative performance of current staging systems. Ann Surg Oncol 20(4):1170-8, 2013. e-Pub 2013. PMID: 23212760.
145. Hsu C, Rashid A, Xing Y, Chiang YJ, Chagpar RB, Fournier KF, Chang GJ, You YN, Feig BW, Cormier JN. Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtype. J Surg Oncol 107(2):136-43, 2013. e-Pub 2013. PMID: 22767417.
146. Tzeng CW, Aloia TA, Vauthey JN, Chang GJ, Ellis LM, Feig BW, Curley SA, Skibber JM, Abdalla EK, You YN, Rodriguez-Bigas MA. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis. Ann Surg Oncol 20(2):482-90, 2013. e-Pub 2013. PMID: 22932858.
147. Park IJ, You YN, Skibber JM, Rodriguez-Bigas MA, Feig B, Nguyen S, Hu CY, Chang GJ. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy. Dis Colon Rectum 56(2):135-41, 2013. e-Pub 2013. PMID: 23303140.
148. Truong AR, Rodriguez-Bigas MA, Nguyen ST, Kaur H, Ernst RD, You YN. Superior mesenteric artery syndrome after ileal pouch anal anastomosis. Am Surg 79(1):E14-6, 2013. e-Pub 2013. PMID: 23317590.
149. You YN, Roses RE, Chang GJ, Rodriguez-Bigas MA, Feig BW, Slack R, Nguyen S, Skibber JM. Multimodality salvage of recurrent disease after local excision for rectal cancer. Dis Colon Rectum 55(12):1213-9, 2012. e-Pub 2012. PMID: 23135578.
150. Garrett CR, George B, Viswanathan C, Bhadkamkar NA, Wen S, Baladandayuthapani V, You YN, Kopetz ES, Overman MJ, Kee BK, Eng C. Survival benefit associated with surgical oophorectomy in patients with colorectal cancer metastatic to the ovary. Clin Colorectal Cancer 11(3):191-4, 2012. e-Pub 2012. PMID: 22280844.
151. Hyngstrom JR, Hu CY, Xing Y, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MA, Cormier JN, Chang GJ. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the national cancer data base. Ann Surg Oncol 19(9):2814-21, 2012. e-Pub 2012. PMID: 22476818.
152. Abbott DE, Cantor SB, Hu CY, Aloia TA, You YN, Nguyen S, Chang GJ. Optimizing clinical and economic outcomes of surgical therapy for patients with colorectal cancer and synchronous liver metastases. J Am Coll Surg 215(2):262-70, 2012. e-Pub 2012. PMID: 22560316.
153. Park IJ, You YN, Agarwal A, Skibber JM, Rodriguez-Bigas MA, Eng C, Feig BW, Das P, Krishnan S, Crane CH, Hu CY, Chang GJ. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol 30(15):1770-6, 2012. e-Pub 2012. PMID: 22493423.
154. Chang GJ, You YN, Park IJ, Kaur H, Hu CY, Rodriguez-Bigas MA, Skibber JM, Ernst RD. Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation. Dis Colon Rectum 55(4):371-7, 2012. e-Pub 2012. PMID: 22426259.
155. Chagpar R, Xing Y, Chiang YJ, Feig BW, Chang GJ, You YN, Cormier JN. Adherence to stage-specific treatment guidelines for patients with colon cancer. J Clin Oncol 30(9):972-9, 2012. e-Pub 2012. PMID: 22355049.
156. Park IJ, You YN, Schlette E, Nguyen S, Skibber JM, Rodriguez-Bigas MA, Chang GJ. Reverse-hybrid robotic mesorectal excision for rectal cancer. Dis Colon Rectum 55(2):228-33, 2012. e-Pub 2012. PMID: 22228169.
157. You YN, Xing Y, Feig BW, Chang GJ, Cormier JN. Young-onset colorectal cancer: is it time to pay attention?. Arch Intern Med 172(3):287-9, 2012. e-Pub 2012. PMID: 22157065.
158. Zielinski MD, Merchea A, Heller SF, You YN. Emergency management of perforated colon cancers: how aggressive should we be?. J Gastrointest Surg 15(12):2232-8, 2011. e-Pub 2011. PMID: 21913040.
159. Sagebiel TL, Faria SC, Aparna B, Sacks JM, You YN, Bhosale PR. Pelvic reconstruction with omental and VRAM flaps: anatomy, surgical technique, normal postoperative findings, and complications. Radiographics 31(7):2005-19, 2011. e-Pub 2011. PMID: 22084184.
160. You YN, Dozois EJ, Boardman LA, Aakre J, Huebner M, Larson DW. Young-Onset rectal cancer: presentation, pattern of care and long-term oncologic outcomes compared to a matched older-onset cohort. Ann Surg Oncol 18(9):2469-76, 2011. e-Pub 2011. PMID: 21448750.
161. You YN, Habiba H, Chang GJ, Rodriguez-bigas MA, Skibber JM. Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer. Ann Surg Oncol 18(4):989-96, 2011. e-Pub 2011. PMID: 21132391.
162. You YN, Wolff BG, Boardman LA, Riegert-Johnson DL, Qin R. Peutz-Jeghers syndrome: a study of long-term surgical morbidity and causes of mortality. Fam Cancer 9(4):609-16, 2010. e-Pub 2010. PMID: 20571886.
163. Shi Q, You YN, Nelson H, Allen MS, Winchester D, Stewart A, Young-Fadok T, Decker PA, Green EM, Holton SJ, Ballman KV. Cancer registries: a novel alternative to long-term clinical trial follow-up based on results of a comparative study. Clin Trials 7(6):686-95, 2010. e-Pub 2010. PMID: 20729254.
164. You YN, Leibovitch BC, Que FG. Hepatic metastasectomy for testicular germ cell tumors: is it worth it?. J Gastrointest Surg 13(4):595-601, 2009. e-Pub 2009. PMID: 19190967.
165. You YN, Short KR, Jourdan M, Klaus KA, Walrand S, Nair KS. The effect of high glucocorticoid administration and food restriction on rodent skeletal muscle mitochondrial function and protein metabolism. PLoS One 4(4):e5283, 2009. e-Pub 2009. PMID: 19381333.
166. You YN, Chua HK, Nelson H, Hassan I, Barnes SA, Harrington J. Segmental vs. extended colectomy: measurable differences in morbidity, function, and quality of life. Dis Colon Rectum 51(7):1036-43, 2008. e-Pub 2008. PMID: 18470560.
167. Hassan I, You YN, Cima RR, Larson DW, Dozois EJ, Barnes SA, Pemberton JH. Hand-assisted versus laparoscopic-assisted colorectal surgery: Practice patterns and clinical outcomes in a minimally-invasive colorectal practice. Surg Endosc 22(3):739-43, 2008. e-Pub 2008. PMID: 17704883.
168. You YQ, Ling PR, Qu JZ, Bistrian BR. Effects of medium-chain triglycerides, long-chain triglycerides, or 2-monododecanoin on fatty acid composition in the portal vein, intestinal lymph, and systemic circulation in rats. JPEN J Parenter Enteral Nutr 32(2):169-75, 2008. e-Pub 2008. PMID: 18407910.
169. Hassan I, You YN, Shyyan R, Dozois EJ, Smyrk TC, Okuno SH, Schleck CD, Hodge DO, Donohue JH. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Ann Surg Oncol 15(1):52-9, 2008. e-Pub 2008. PMID: 18000711.
170. You YN, Thompson GB, Young WF, Larson D, Farley DR, Richards M, Grant CS. Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: Operative outcomes, long-term function, and quality of life. Surgery 142(6):829-36; discussion 836.e1, 2007. e-Pub 2007. PMID: 18063064.
171. You YN, Baxter NN, Stewart A, Nelson H. Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. Ann Surg 245(5):726-33, 2007. e-Pub 2007. PMID: 17457165.
172. Hassan I, Pemberton JH, Young-Fadok TM, You YN, Drelichman ER, Rath-Harvey D, Schleck CD, Larson DR. Ileorectal anastomosis for slow transit constipation: long-term functional and quality of life results. J Gastrointest Surg 10(10):1330-6; discussion 1336-7, 2006. e-Pub 2006. PMID: 17175451.
173. You YN, Jacobs L, Martinez ED, Budinger SC, Wittlief EJ, Myles SK, Ota DM, Oncology Group ACOS. Improved surgeon performance in clinical trials: an analysis of quality assurance audits from the American College of Surgeons Oncology Group. J Am Coll Surg 203(3):269-76, 2006. e-Pub 2006. PMID: 16931297.
174. Hassan I, You YN, Dozois EJ, Shayyan R, Smyrk TC, Okuno SH, Donohue JH. Clinical, pathologic, and immunohistochemical characteristics of gastrointestinal stromal tumors of the colon and rectum: implications for surgical management and adjuvant therapies. Dis Colon Rectum 49(5):609-15, 2006. e-Pub 2006. PMID: 16552495.
175. You YN, Tefferi A, Nagorney DM. Outcome of splenectomy for thrombocytopenia associated with systemic lupus erythematosus. Ann Surg 240(2):286-92, 2004. e-Pub 2004. PMID: 15273553.
176. Der DE, You YQ, Wolter TD, Bowen DA, Dale LC. A free smoking intervention clinic initiated by medical students. Mayo Clin Proc 76(2):144-51, 2001. e-Pub 2001. PMID: 11213302.
177. You YQ, Ling PR, Qu Z, Bistrian BR. Effect of continuous enteral medium-chain fatty acid infusion on lipid metabolism in rats. Lipids 33(3):261-6, 1998. e-Pub 1998. PMID: 9560800.
178. Grassi CJ, Bettmann MA, Rogoff P, Reagan K, Harrington DP. Femoral arteriovenous fistula after placement of a Kimray-Greenfield filter. AJR Am J Roentgenol 151(4):681-2, 1988. e-Pub 1988. PMID: 3262268.

Invited Articles

1. Park KU, Mamounas EP, Katz MHG, Unzeitig G, Carpizo D, You YN, Francescatti A, Hunt KK, Boughey JC. Clinical Trials for the Surgical Oncologist: Opportunities and Hurdles. Ann Surg Oncol 27(7):2269-2275, 2020. e-Pub 2020. PMID: 32318946.
2. Group S. Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019). Eur J Surg Oncol 46(6):955-966, 2020. e-Pub 2020.
3. Healy MA, Thirumurthi S, You YN. Screening high-risk populations for colon and rectal cancers. J Surg Oncol 120(5):858-863, 2019. e-Pub 2019. PMID: 31368175.
4. Yang Y, You YN. Comprehensive clinical genetics care for patients with inherited colorectal cancer associated with Lynch syndrome: Western and Asian perspectives. Chin Clin Oncol 7(1):9, 2018. e-Pub 2018. PMID: 29486568.
5. Monson JRT, Dietz DW, Boughey JC, You YN. Improving rectal cancer outcomes through advocacy, education, and research: The OSTRiCh Consortium and the new NAPRC. Bull Am Coll Surg 101(11):45-6, 2016. e-Pub 2016. PMID: 28937195.
6. You YN, Eng C, Aloia TA. Multidisciplinary management of stage IV colon cancer. Seminars in Colon and Rectal Surgery, 2016. e-Pub 2016.
7. George TJ, Wu C, You YN. NRG GI002: Moving the needle toward TNT in locally advanced rectal cancer. Bull Am Coll Surg 101(10):61-2, 2016. e-Pub 2016. PMID: 28937723.
8. Kurtzman SH, Boughey JC, You YN. Why is surgeon qualification important for clinical trials, and how can it be achieved?. Bull Am Coll Surg 101(9):51-2, 2016. e-Pub 2016. PMID: 28941372.
9. Fleshman JW, Boughey JC, You YN. Rectal cancer resection: Laparoscopic or open--which way forward?. Bull Am Coll Surg 101(1):64-66, 2016. e-Pub 2016. PMID: 26891508.
10. Krouse RS, You YN. Prospective comparative effectiveness trial for malignant bowel obstruction: SWOG S1316. Bull Am Coll Surg 100(12):49-50, 2015. e-Pub 2015. PMID: 26749971.
11. Zell J, You YN, Boughey JC. PACES trial: Evaluating the effectiveness of eflornithine and sulindac in preventing colon adenomas. Bull Am Coll Surg 100(8):70-1, 2015. e-Pub 2015. PMID: 26419059.
12. Roses RE, Datta J, You YN, Boughey JC. Multimodality treatment considerations in esophageal and gastric cancer: Are we making progress?. Bull Am Coll Surg 100(7):63-5, 2015. e-Pub 2015. PMID: 26248400.
13. Martin LW, Veeramachaneni NKm Katz MH, You YN, Boughey JC, Nelson H, Hunt KK. New manual for cancer surgery issued: Operative standards for cancer surgery. Bull Am Coll Surg 100(6), 2015. e-Pub 2015.
14. Altorki N, Kohman LJ, Veit LJ, You YN, Boughey JC. Limited resection as a cure for early lung cancer: time to challenge the gold standard?. Bull Am Coll Surg 100(5), 2015. e-Pub 2015.
15. Weiser MR, Fichera A, Schrag D, Boughey JC, You YN. Progress in the PROSPECT trial: Precision treatment for rectal cancer. Bull Am Coll Surg 100(4), 2015. e-Pub 2015.
16. You YN, Bednarski B. Developing a research skill set. Clin Colon Rectal Surg 27(2):48-54, 2014. e-Pub 2014. PMID: 25067917.
17. You YN, Nelson H. A paradigm shift in rectal cancer treatment: The PROSPECT trial. Bull Am Coll Surg, 2012. e-Pub 2012.
18. You YN. Local excision: is it an adequate substitute for radical resection in T1/T2 patients?. Semin Radiat Oncol 21(3):178-84, 2011. e-Pub 2011. PMID: 21645862.
19. You YN, Ota D, Nelson H. The American College of Surgeons Oncology Group. Surgery 145(6):587-90, 2009. e-Pub 2009. PMID: 19486756.
20. You YN, Lakhani V, Wells SA. New directions in the treatment of thyroid cancer. J Am Coll Surg 205(4 Suppl):S45-8, 2007. e-Pub 2007. PMID: 17916518.
21. You YN, Wells SA. Role of surgeons in clinical trials for thyroid cancer. World J Surg 31(5):987-95, 2007. e-Pub 2007. PMID: 17426898.
22. You YN, Lakhani VT, Wells SA. The role of prophylactic surgery in cancer prevention. World J Surg 31(3):450-64, 2007. e-Pub 2007. PMID: 17308850.
23. You YN, Jacobs L, Martinez E, Ota DM. The audit process and how to ensure a successful audit. Cancer Treat Res 132:179-97, 2007. e-Pub 2007. PMID: 17305022.
24. Lakhani VT, You YN, Wells SA. The multiple endocrine neoplasia syndromes. Annu Rev Med 58:253-65, 2007. e-Pub 2007. PMID: 17037976.
25. You YN, Wells SA, Oncology Group ACOS. Clinical trials in surgery: the role of the American College of Surgeons Oncology Group. World J Surg 30(7):1147-51, 2006. e-Pub 2006. PMID: 16794900.
26. You YN, Lakhani V, Wells SA, Moley JF. Medullary thyroid cancer. Surg Oncol Clin N Am 15(3):639-60, 2006. e-Pub 2006. PMID: 16882502.
27. You YN, Hunt KK, Posner MC, Putnam JB, Nelson H, Ota DM, Pisters PW. Operative trials: the opportunity beckons-an update on the American College of Surgeons Oncology Group. Surgery 139(4):455-9, 2006. e-Pub 2006. PMID: 16627052.

Review Articles

1. Weinberg, BA, Murphy, CC, Freyer, DR, Greathouse, KL, Blancato, J, Stoffel, EM, Drewes, JL, Blaes, A, Salsman, JM, You, YN, Arem, H, Mukherji, R, Kanth, P, Hu, X, Fabrizio, A, Hartley, M, Giannakis, M, Marshall, JL. Rethinking the rise of early-onset gastrointestinal cancers. JNCI Cancer Spectrum 9(1), 2025. e-Pub 2025. PMID: 39814070.
2. Ochiai K, Bhutiani N, Ikeda A, Uppal A, White MG, Peacock O, Messick CA, Bednarski BK, You YN, Skibber JM, Chang GJ, Konishi T. Total Neoadjuvant Therapy for Rectal Cancer: Which Regimens to Use?. Cancers (Basel) 16(11), 2024. e-Pub 2024. PMID: 38893212.
3. Bhutiani N, Peacock O, Uppal A, You YN, Bednarski BK, Skibber JM, Messick C, White MG, Chang GJ, Konishi T. The current multidisciplinary management of rectal cancer. Ann Gastroenterol Surg 8(3):394-400, 2024. e-Pub 2024. PMID: 38707228.
4. Spaander MCW, Zauber AG, Syngal S, Blaser MJ, Sung JJ, You YN, Kuipers EJ. Young-onset colorectal cancer. Nat Rev Dis Primers 9(1):21, 2023. e-Pub 2023. PMID: 37105987.
5. Cavestro GM, Mannucci A, Balaguer F, Hampel H, Kupfer SS, Repici A, Sartore-Bianchi A, Seppälä TT, Valentini V, Boland CR, Brand RE, Buffart TE, Burke CA, Caccialanza R, Cannizzaro R, Cascinu S, Cercek A, Crosbie EJ, Danese S, Dekker E, Daca-Alvarez M, Deni F, Dominguez-Valentin M, Eng C, Goel A, Guillem JG, BBSL H, Kahi C, Kalady MF, Kastrinos F, Kühn F, Laghi L, Latchford A, Liska D, Lynch P, Malesci A, Mauri G, Meldolesi E, Møller P, Monahan KJ, Möslein G, Murphy CC, Nass K, Ng K, Oliani C, Papaleo E, Patel SG, Puzzono M, Remo A, Ricciardiello L, Ripamonti CI, Siena S, Singh SK, Stadler ZK, Stanich PP, Syngal S, Turi S, Urso ED, Valle L, Vanni VS, Vilar E, Vitellaro M, You YN, Yurgelun MB, Zuppardo RA, Stoffel EM, Ereditarietà Tumori AIF, Gastrointestinal Cancer CGOTAOI, Tumour Group EH, Hereditary Tumours ATISFG. Delphi initiative for early-onset colorectal cancer (DIRECt). International Management Guidelines. Clin Gastroenterol Hepatol 21(3):581-603.e33, 2023. e-Pub 2023. PMID: 36549470.
6. Konishi T, You YN. Complete Mesocolic Excision and Extent of Lymphadenectomy for the Treatment of Colon Cancer. Surg Oncol Clin N Am 31(2):293-306, 2022. e-Pub 2022. PMID: 35351279.
7. Kanikarla Marie, P, Fowlkes, NW, Afshar-Kharghan, V, Martch, SL, Sorokin, A, Shen, JY, Morris, VK, Dasari, NV, You, YN, Sood, AK, Overman, MJ, Kopetz, S, Menter, DG. The Provocative Roles of Platelets in Liver Disease and Cancer. Frontiers in Oncology 11, 2021. e-Pub 2021. PMID: 34367949.
8. Dasari A, Morris VK, Allegra CJ, Atreya C, Benson AB, Boland P, Chung K, Copur MS, Corcoran RB, Deming DA, Dwyer A, Diehn M, Eng C, George TJ, Gollub MJ, Goodwin RA, Hamilton SR, Hechtman JF, Hochster H, Hong TS, Innocenti F, Iqbal A, Jacobs SA, Kennecke HF, Lee JJ, Lieu CH, Lenz HJ, Lindwasser OW, Montagut C, Odisio B, Ou FS, Porter L, Raghav K, Schrag D, Scott AJ, Shi Q, Strickler JH, Venook A, Yaeger R, Yothers G, You YN, Zell JA, Kopetz S. ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper. Nat Rev Clin Oncol, 2021. e-Pub 2021. PMID: 32632268.
9. Boardman LA, Vilar E, You YN, Samadder J. AGA Clinical Practice Update on Young Adult Onset Colorectal Cancer Diagnosis and Management: Expert Review. Clin Gastroenterol Hepatol 18(11):2415-2424, 2020. e-Pub 2020. PMID: 32525015.
10. You YN, Hardiman KM, Bafford A, Poylin V, Francone TD, Davis K, Paquette IM, Steele SR, Feingold DL. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer. Dis Colon Rectum 63(9):1191-1222, 2020. e-Pub 2020. PMID: 33216491.
11. Coletta AM, Peterson SK, Gatus LA, Krause KJ, Schembre SM, Gilchrist SC, Arun B, You YN, Rodriguez-Bigas MA, Strong LL, Lu KH, Basen-Engquist K. Diet, weight management, physical activity and Ovarian & Breast Cancer Risk in women with BRCA1/2 pathogenic Germline gene variants: systematic review. Hered Cancer Clin Pract 18:5, 2020. e-Pub 2020. PMID: 32165993.
12. Coletta AM, Peterson SK, Gatus LA, Krause KJ, Schembre SM, Gilchrist SC, Pande M, Vilar E, You YN, Rodriguez-Bigas MA, Strong LL, Lynch PM, Lu KH, Basen-Engquist K. Energy balance related lifestyle factors and risk of endometrial and colorectal cancer among individuals with lynch syndrome: a systematic review. Fam Cancer 18(4):399-420, 2019. e-Pub 2019. PMID: 31236808.
13. Mork M, Hubosky SG, Roupret M, Margulis V, Raman J, Lotan Y, O'Brien T, You YN, Shariat SF, Matin SF. Lynch Syndrome: A Primer for Urologists and Panel Recommendations. J Urol 194(1):21-9, 2015. e-Pub 2015. PMID: 25711197.
14. You YN, Rustin RB, Sullivan JD. Oncotype DX® colon cancer assay for prediction of recurrence risk in patients with stage II and III colon cancer: A review of the evidence. Surg Oncol 24(2):61-6, 2015. e-Pub 2015. PMID: 25770397.
15. Kaur H, Choi H, You YN, Rauch GM, Jensen CT, Hou P, Chang GJ, Skibber JM, Ernst RD. MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics 32(2):389-409, 2012. e-Pub 2012. PMID: 22411939.

Professional Educational Materials

1. You YN. Patient Education: MYH-Associated Polyposis (MAP), 2012.
2. You YN. Patient Education: Hereditary Diffuse Gastric Cancer, 2012.

Other Articles

1. You YN Ostomy. American Society of Colon and Rectal Surgeons Patient Education Brochure, 2013.

Editorials

1. Ricciardiello L, You YN. Enhancing Standardization in the Pediatric Management of Hereditary Polyposis Syndromes. Cancer Prev Res (Phila):OF1-OF3, 2025. PMID: 40843510.
2. Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. ASO Author Reflections: The Patient First Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol 30(9):5401-5402, 2023. PMID: 37322282.
3. You YN, Rodriguez-Bigas MA, Das P, Healy M, Chiang YJ, George T, Vilar E. Comment on "A National Cancer Database Analysis of Microsatellite Instability and Pathologic Complete Response in Locally Advanced Rectal Cancer". Ann Surg 274(2):e197-e198, 2021. PMID: 31972642.
4. Yang Y, You YN. ASO Author Reflections: Toward Molecularly-Driven Personalized Care for Young Adults with Rectal Cancer. Ann Surg Oncol 26(S3):656-657, 2019. PMID: 31297673.
5. Lee LD, You YN. Perioperative safety in patients with resectable synchronous colorectal liver metastases. Chin Clin Oncol 8(S1):S23, 2019. PMID: 31431038.
6. You YN. Anticipating phenotypic differences from genetic mutations. Dis Colon Rectum 58(1):143-4, 2015. PMID: 25489706.
7. Conrad C, You YN, Vauthey JN. In patients with colorectal liver metastases, can we still rely on number to define treatment and outcome?. Oncology 27(11):1078-1086, 2013.
8. You YN, Vilar E. Classifying MMR variants: time for revised nomenclature in Lynch syndrome. Clin Cancer Res 19(9):2280-2, 2013. PMID: 23532885.

Abstracts

1. You YN, Newhook TE, Tzeng CD, Cao H, Chun YS, Peacock O, Bednarski BK, Konishi T, Perrier ND, Vauthey JN. Survival Gains in patients with Young-Onset Colorectal Cancer and Synchronous Liver Metastases. AHPBA 2024, 2024. e-Pub 2024.
2. Uppal A, Helmink B, Grotz TE, Konishi T, Fournier KF, Nguyen S, Taggart MW, Shen JP, Bednarski BK, You YN, Chang GJ. ASO Visual Abstract: What is the Risk for Peritoneal Metastases and Survival Afterwards in T4 Colon Cancers?. Ann Surg Oncol. e-Pub 2022. PMID: 35298760.
3. Swords DS, Bednarski BK, Messick CA, Tillman MM, Chang GJ, You YN. ASO Visual Abstract: Quality and Location of the Surgical Episode Mediate a Large Proportion of Socioeconomic-Based Survival Disparities for Patients with Resected Stages I-III Colon Cancer. Ann Surg Oncol, 2021. e-Pub 2021. PMID: 34499257.
4. Hester RH, Taniguchi C, Holliday EB, Koay EJ, Das P, Minchy B, Rashid A, Mehdizadeh A, Ohinata A, Messick C, You Y, Bednarski BK, Skibber J, Wolff RA, Eng C, Morris VK. CEA as a pharmacodynamic biomarker for metastatic anal cancer. 2018 Gastrointestinal Cancers Symposium, 2018. e-Pub 2018.
5. Hester RH, Taniguchi C, Holliday EB, Koay EJ, Das P, Minchy B, Rashid A, Mehdizadeh A, Ohinata A, Messick C, You Y, Bednarski BK, skibber J, Wolff RA, Eng C, Morris VK. CEA as a pharmacodynamic biomarker for metastatic anal cancer. 2018 Gastrointestinal Cancers Symposium, San Francisco, CA (Abstract 684), 2018. e-Pub 2018.
6. Lee J, Emelogu IK, Coronell E, Nogueras-Gonzalez GM, Lum P, Ross WA, Rajul GS, Lynch PM, Thirumurthi S, Stroehlein JR, Wang Y, You YN, Weston BR. ARE SEMS (SELF-EXPANDING METAL STENTS) A SAFE AND SUCCESSFUL BRIDGE TO SURGERY OR. Digestive Disease Week in Washington, D.C. June 2-5, 2018, 2018. e-Pub 2018.
7. You YN. Multigene Hotspot Mutational Profiling of Young vs. Later Age-of-onset Colorectal Cancer Using Next-Generation Sequencing. ASCRS Annual Scientific and Tripartite Meeting in Seattle, WA, 2017. e-Pub 2017.
8. Zlawadi Z, Phatak U, Kao L, Hu C, Bailey C, You YN, Chang GJ. Comparative effectiveness of primary tumor resection in metastatic colon cancer: An instrumental variable analysis. 2015 Society of Surgical Oncology Annual Symposium, Houston, Texas, 2015. e-Pub 2015.
9. Ayoub H, You YN, Cao H, C-Y H, Bailey C, Chang G, Rodriguez-Bigas M, Skibber J, Westney OL. Factors correlating with sexual interest and function in long-term colorectal cancer survivors. 2015 Annual Meeting of the American Urological Association Education and Research Inc., New Orleans, LA (Abstract 403), 2015. e-Pub 2015.
10. Conrad C, You YN, Bailey CE, Zorzi D, Kopetz S, Aloia TA, Vauthey JN. Adaption of reversed treatment sequencing approach contributes to improved survival in patients with rectal cancer and resectable synchronous liver metastases. 2015 Society of Surgical Oncology Annual Symposium, Houston, Texas, 2015. e-Pub 2015.
11. You YN, Conrad C, Bailey CE, Rodriguez-Bigas MA, Skibber JM, Das P, Zorzi D, Aloia TA, Vauthey JN, Change GJ. Is pelvic radiation necessary for the curative treatment of stage IV rectal cancer with resectable metastases?. 2015 Society of Surgical Oncology Annual Symposium, Houston, Texas, 2015. e-Pub 2015.
12. You YN, Vilar E, Cuddy A, Wu C, Lynch PM, Eng C, Rodriguez-Bigas MA, Chang GJ. Are young adults with colorectal cancer doing enough to stay healthy?. AACR Annual Meeting 2015, Philadelphia, PA, 2015. e-Pub 2015.
13. You YN, Chang K, Chen K, Mehdizadeh A, Cuddy A, Lieu C, Meric-Bernstam F, Shaw-Miller K, Vilar E, contributing author ECE, author EC. Somatic mutations in young-onset colorectal cancer unrelated to hereditary syndromes: A comparative study using high depth targeted exome sequencing. 2015 Gastrointestinal Cancers Symposium (Abstract 140550), 2015. e-Pub 2015.
14. Ayoub H, You YN, Cao H, Hu, C-Y, Bailey C, Chang G Rodriguez-Bigas M, Skibber J, Westney L. Factors correlating with sexual interest and function in long-term colorectal cancer survivors. The World Meeting on Sexual Medicine, Sao Paulo, Brazil, 2014. e-Pub 2014.
15. You YN. Risk and distribution of secondary cancers among long-term survivors of colon and rectal cancer. 2015 Cancer Survivorship Research Symposium, UT MD Anderson Cancer Center, Houston, TX, 2014. e-Pub 2014.
16. Tran Cao HS, Bailey CE, Hu CY, Chang GJ, Feig B, Rodriguez-Bigas MA, Nguyen S, Skibber JM, You YN. Young age-at-diagnosis influences quality of life among long-term survivors of colorectal cancer. Society of Surgical Oncology 67th Annual Cancer Symposium, Phoenix, AZ (Abstract 1851010), 2014. e-Pub 2014.
17. Clarke CN, Agarwal AK, You YN, Rodriguez-Bigas MA, Skibber JM, Schlette E, Nguyen S, Chang GJ. Robotic cylindrical APR: a technically feasible and oncologically sound approach to surgical resection of anorectal cancers. American Society of Colon and Rectal Surgeons Abstract Book, 2014. e-Pub 2014.
18. Phatak UR, Hu C, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MA, Cormier JM, Kao LS, Chang GJ. Primary tumor resection in metastatic colon cancer: A propensity score analysis of the National Cancer Database. Academic Surgical Congress, San Diego, CA (Abstract ACS20140516), 2014. e-Pub 2014.
19. You YN, Bednarski B, Vilar-Sanchez E, Chang GJ, Feig BW, Skibber JM, Ellis L, Bannon S, Mork M, Lynch PM, Rodriguez-Bigas MA. Lynch or not Lynch: Clinical translation of findings from a prospective surgeon-triggered program to universally screen for mismatch-repair deficiency in patients with colorectal cancer. American Society of Colon & Rectal Surgeons Annual Meeting, Hollywood, FL (Abstract P89), 2014. e-Pub 2014.
20. Tran Cao HS, Bailey CE, Hu CY, Chang GJ, Feig B, Rodriguez-Bigas MA, Nguyen S, Skibber JM, You YN. Young age-at-diagnosis influences quality of life among long-term survivors of colorectal cancer. The University of Texas MD Anderson Cancer Center 2014 Cancer Survivorship Research Symposium (Abstract 0041), 2014. e-Pub 2014.
21. You YN, Chang K, Chen K, Mehdizadeh A, Cuddy A, Lieu C, Meric-Bernstam F, Shaw-Miller K, Vilar E, Eng C. Somatic mutations in young-onset colorectal cancer unrelated to hereditary syndromes: A comparative study using high-depth targeted exome sequencing. 2015 Gastrointestinal Cancers Symposium Annual Meeting, San Francisco, CA (Abstract 140550), 2014. e-Pub 2014.
22. Westney O, Livengood M, Yuan C, Bailey CE, Tran Cao H, Nguyen S, You YN. Urinary symptoms persist in young colorectal survivors who underwent pelvic surgery at long-term follow-up. The University of Texas MD Anderson Cancer Center 2014 Cancer Survivorship Research Symposium Excellence in Research Awardees (Abstract 049), 2014. e-Pub 2014.
23. Clarke CN, Agarwal AK, You YN, Bednarski B, Rodriguez-Bigas MA, Skibber JM, Nguyen S, Schlette E, Chang GJ. Robotic extended resections for locally advanced anorectal cancer. Proceedings of the Society of Surgical Oncology, 2014. e-Pub 2014.
24. You YN, Vilar-Sanchez E, Slack R, Chang GJ, Nguyemn ST, Cuddy A, Khose S, Wisniewski W, Bannon SA, Mork MM, Lynch PM, Rodriguez-Bigas MA. Lynch syndrome testing in ethnically diverse patients: Mutation spectrum and performance of prediction models. American Society of Clinical Oncology Annual Meeting, Chicago, IL (Abstract 116305;1546), 2013. e-Pub 2013.
25. You YN, Bednarski B, Chang GJ, Khose S, Nguyen S, Feig B, Skibber J, Rodriquez-Bigas M. DNA mismatch repair defects do not account for the majority of newly diagnosed young-onset colorectal cancers. American Society of Colon and Rectal Surgery Annual Meeting, Phoenix, AZ (Abstract 1584822), 2013. e-Pub 2013.
26. You YN, Chang GJ, Bannon S, Mork M, Vilar Sanchez E, Cuddy A, Lynch PM, Rodriguez-Bigas MA. Lynch Syndrome-associated rectal cancer: Characteristics and outcomes. 2013 Society of Pelvic Surgeons Annual Meeting, Dusseldorf/Leiden - Germany, 2013. e-Pub 2013.
27. Rodriguez-Bigas MA, Nguyen S, Vilar-Sanchez E, Bannon S, Mork M, Cuddy A, Lynch PM, You YN. Colorectal cancer in Lynch Syndrome: No age discrimination. 5th Biennial Meeting International Society for Gastrointestinal Hereditary Tumours InSiGHT, Cairns, Australia, 2013. e-Pub 2013.
28. Vilar Sanchez V, Wu W, Bhatia G, Cuddy A, Mork MM, Bannon SA, Lynch PM, Rodriguez-Bigas MA, Taggart MW, You YN. Can microsatellite status of colorectal cancer (CRC) be reliably assessed after neoadjuvant therapy?. 2013 American Society of Clinical Oncology Annual Meeting, Chicago, IL, 2013. e-Pub 2013.
29. You YN, Chang GJ, Cormier J, Feig BW, Rodriquez-Bigas M, Skibber JM. A framework for developing quality measures of survivorship care in colorectal cancer. The University of Texas MD Anderson Cancer Center Cancer Survivorship Research Retreat, Houston, TX, 2013. e-Pub 2013.
30. Bannon SA, Rodriguez-Bigas M, Lynch P, Mork M, Nguyen S, Peterson SK, Karen L, You YN. "No thanks": Which patients decline genetic testing for Lynch Syndrome after finding tumor microsatellite instability?. Collaborative Group of the Americas on Inherited Colorectal Cancer 16th Annual Meeting, Boston, MA, 2012. e-Pub 2012.
31. Abbott DE, Cantor SB, Rodriguez-Bigas MA, Chang GJ, Lynch PM, Feig BW, Skibber JM, You YN. Detecting hereditary nonpolyposis colorectal cancer syndrome (HNPCC) in colorectal cancer (CRC) patients: Optimal strategies at lower costs. American Society of Clinical Oncology Gastrointestinal Cancers Symposium, San Francisco, CA J Clin Oncol 30(Suppl 4; Abstract 396), 2012. e-Pub 2012.
32. Haynes A, Chiang YJ, Feig B, Xing Y, Chang G, You YN, Cormier J. Association between delays in adjuvant chemotherapy for stage II and III colon cancer and increased mortality. American Society of Clinical Oncology Gastrointestinal Symposium, San Francisco, CA J Clin Oncol 30(Suppl 4; Abstract 541), 2012. e-Pub 2012.
33. Russell MC, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Feig BW, You YN. Detection of hereditary nonpolyposis colorectal cancer (HNPCC) in non-Caucasian patients. American Society of Clinical Oncology Gastrointestinal Cancer Symposium, San Francisco, CA J Clin Oncol 30(Suppl 3; Abstract 417), 2012. e-Pub 2012.
34. Boland GM, Chiang Y, Chagpar R, Xing Y, Hu CY, Feig BW, Chang GJ, You YN, Cormier JN. Association of NCCN guideline adherence with improved survival in high-risk stage II and III colon cancer. American Society of Clinical Oncology Gastrointestinal Cancers Symposium, San Francisco, CA J Clin Oncol 30(Suppl 4; Abstract 543), 2012. e-Pub 2012.
35. Chang GJ, Park IJ, Eng C, You YN, Kopetz S, Overman MJ, Rodriguez-Bigas MA, Skibber JM. Exploratory analysis of adjuvant chemotherapy benefits after preoperative chemoradiotherapy and radical resection for rectal cancer. American Society of Clinical Oncology Annual Meeting, Chicago, IL J Clin Oncol 30(Suppl; Abstract 3556), 2012. e-Pub 2012.
36. Russell MC Chiang YJ, Feig BW, Chang GJ, Rodriguez-Bigas MA, Skibber JM, Chagpar R, Cormier JN, You YN. Lymph nodes metastasis in patients with early pathologic T-stage rectal cancers: What does local excision leave behind?. American Society of Clinical Oncology Gastrointestinal Cancer Symposium, San Francisco, CA J Clin Oncol 30(Suppl 4; Abstract 537), 2012. e-Pub 2012.
37. You YN, Chang GJ, Feig BW, Roses RE, Rodriguez-Bigas MA, Skibber JM. Multimodality salvage of failure after local excision for rectal cancer. American Society of Colon and Rectal Surgeons Annual Meeting, San Antonio, TX, 2012. e-Pub 2012.
38. Tzeng CD, Chang GJ, Curley SA, Vauthey JN, Ellis LM, Skibber JM, Feig BW, Abdalla EK, Aloia TA, You YN, Rodriquez-Bigas MA. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: A matched case-control analysis. American Society of Clinical Oncology Gastrointestinal Cancers Symposium, San Francisco, CA J Clin Oncol 30(Suppl 4; Abstract 629), 2012. e-Pub 2012.
39. Haynes A, Chiang YJ, Feig B, Xing Y, Chang G, You YN, Cormier J. Association between delays in adjuvant chemotherapy for stage II and III colon cancer and increased mortality. Society for Surgical Oncology 65th Annual Cancer Symposium, Orlando, FL, 2012. e-Pub 2012.
40. Russell MC, Hu CY, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MA, Xing Y, Cormier JN, Nelson H, Chang GJ. Targeting process improvement for rectal cancer surgery. American College of Surgeons' 98th Annual Clinical Congress, Chicago, IL, 2012. e-Pub 2012.
41. Russell MC, Chiang YJ, Feig BW, Chang GJ, Rodriguez-Bigas MA, Skibber JM, Chagpar R, Cormier JN, You YN. Lymph node metastasis in patients with early pathologic T-stage rectal cancers: What does local excision leave behind?. Society for Surgical Oncology 65th Annual Cancer Symposium, Orlando, FL, 2012. e-Pub 2012.
42. Haynes AB, Chiang YS, Boland GM, Xing Y, Masserweh NN, Chang GJ, You YN, Feig BW, Cormier JN. Socioeconomic and clinical factors associated with delayed initiation of adjuvant chemotherapy for stage III colon cancer. American Society of Clinical Oncology Quality Care Symposium, San Diego, CA, 2012. e-Pub 2012.
43. Hyngstrom JR, Rodriguez-Bigas MA, Chang GJ, Taggert MW, Skibber JM, Feig BW, You YN. Microsatellite high colorectal cancer: Does the underlying mechanism for instability matter?. Society for Surgical Oncology 65th Annual Cancer Symposium, Orlando, FL, 2012. e-Pub 2012.
44. Chang J, Hu CY, You YN, Eng C, Rodriguez-Bigas MA, Skibber JM. What determines adjuvant chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer?. American Society of Clinical Oncology Gastrointestinal Cancers Symposium, San Francisco, CA J Clin Oncol 30(Suppl 4; Abstract 546), 2012. e-Pub 2012.
45. You YN, Bannon S, Taggart M, Reeves C, Modaro C, Skibber J, Rodriguez-Bigas M, Lynch PM. Toward universal testing for hereditary nonpolyposis colorectal cancer (HNPCC) syndrome in young patients with colorectal cancer: A quality improvement initiative. Digestive Disease Week, San Diego, CA, 2012. e-Pub 2012.
46. Eng C, Rogers J, Chang GJ, You YN, Das P, Rodriguez-Bigas MA, Ohinata A, Phillips J. Choice of chemotherapy in the treatment of metastatic squamous cell carcinoma of the anal canal. American Society of Clinical Oncology Annual Meeting, Chicago, IL J Clin Oncol 30(Suppl; Abstract 4060), 2012. e-Pub 2012.
47. Hyngstrom JR, Rodriguez-Bigas MA, Chang GJ, Taggert MW, Skibber JM, Feig BW, You YN. Microsatellite high colorectal cancer: Does the underlying mechanism for instability matter?. American Society of Clinical Oncology Gastrointestinal Cancer Symposium, San Francisco, CA J Clin Oncol 30(Suppl 4; Abstract 575), 2012. e-Pub 2012.
48. Mork M, Rodriguez-Bigas M, Lynch P, Bannon S, You YN. Microsatellite-low colorectal cancer: The role of genetic counseling in managing a clinical dilemma. 16th Annual Collaborative Group of the Americas on Inherited Colorectal Cancer, Boston, MA, 2012. e-Pub 2012.
49. Abbott DE, Cantor SB, Rodriguez-Bigas MA, Chang GJ, Lynch PM, Feig BW, Skibber JM, You YN. Detecting hereditary nonpolyposis colorectal cancer syndrome (HNPCC) in colorectal cancer (CRC) patients: Optimal strategies at lower costs. Society for Surgical Oncology 65th Annual Cancer Symposium, Orlando, FL, 2012. e-Pub 2012.
50. Park IJ, Feig BW, Skibber JM, Rodriguez-Bigas MA, You YN, Nguyen ST, Chang GJ. Recurrence patterns after multidisciplinary therapy for rectal cancer in 725 patients. Society for Surgical Oncology 65th Annual Cancer Symposium, Orlando, FL, 2012. e-Pub 2012.
51. Park IJ, Eng C, You YN, Kopetz S, Rodriguez-Bigas MA, Overman MJ, Skibber JM, Chang GJ. Exploratory analysis of adjuvant chemotherapy effects after preoperative chemoradiotherapy and radical resection for rectal cancer. American Society of Clinical Oncology Gastrointestinal Cancers Symposium, San Francisco, CA J Clin Oncol 30(Suppl 4; Abstract 557), 2012. e-Pub 2012.
52. Mitchell MP, Abboud M, Crane C, Eng C, Chang GJ, Rodriguez-Bigas MA, Skibber JM, You YN, Beddar S, Krishnan S, Delclos ME, Das P. Intensity-modulated radiation therapy (IMRT) with concurrent chemotherapy for anal cancer: A large single-institution experience. American Society of Clinical Oncology Gastrointestinal Cancer Symposium, San Francisco, CA J Clin Oncol 30(Suppl 4; Abstract 661), 2012. e-Pub 2012.
53. Russell MC, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Feig BW, You YN. Detection of hereditary nonpolyposis colorectal cancer (HNPCC) in non-caucasian patients. Society for Surgical Oncology Cancer 65th Annual Cancer Symposium, Orlando, FL, 2012. e-Pub 2012.
54. Bannon SA, Mork ME, Ling YK, Brandt A, Rodriguez-Bigas MA, Lynch PM, Peterson SK, Lu K, You YN. Hereditary nonpolyposis colorectal cancer (HNPCC) patient education conference: Impact on patients and families. Collaborative Group of the Americas on Inherited Colorectal Cancer 15th Annual Meeting, Montreal, Canada, 2011. e-Pub 2011.
55. Eng C, Xing Y, You YN, Chang GJ, Das P, Phillips J, Wolff RA, Rodriguez-Bigas MA, Ohinata A, Crane CH. Cisplatin (C) based chemoradiation (CXRT) for locally advanced squamous cell carcinoma (SCCA) of the anal canal(AC): A 20-year perspective. American Society of Clinical Oncology Gastrointestinal Cancer Symposium, San Francisco, CA, 2011. e-Pub 2011.
56. Chagpar R, Xing Y, Hsu C, Cormier JN, Rashid A, Chiang YJ, Feig BW, Chang GJ, You YN. Comparison and validation of three staging systems for neuroendocrine tumors of the colon and rectum. American Society of Colon and Rectal Surgeons Annual Meeting, Vancouver, Canada, 2011. e-Pub 2011.
57. Chagpar R, Cormier JN, Xing Y, Chiang Y, Chang GJ, You YN, Rodriguez-Bigas MA, Skibber JM, Feig BW. Which stage II colon cancer patients are receiving recommendations for adjuvant chemotherapy? An analysis of current practices using the national cancer database. American Society of Colon and Rectal Surgeons Annual Meeting, Vancouver, Canada, 2011. e-Pub 2011.
58. George B, You YN, Viswanathan C, Wen S, Baladandayuthapani V, Overman MJ, Kee BK, Kopetz S, Eng C, Garrett CR. Survival advantage associated with palliative oophorectomy in patients with metastatic colorectal cancer (CRC) to the ovaries (m-CRC-O): A single institution retrospective analysis. American Society of Clinical Oncology Gastrointestinal Cancer Symposium, San Francisco, CA, 2011. e-Pub 2011.
59. Chagpar R, Xing Y, Feig BW, Chiang YJ, You YN, Cormier JN. A nationally representative assessment of prognostic factors associated with neuroendocrine tumors of the colon. Society for Surgery of the Alimentary Tract 52nd Annual Meeting during Digestive Disease Week, Chicago, IL, 2011. e-Pub 2011.
60. You YN, Xing Y, Feig BW, Rodriguez-Bigas MA, Skibber JM, Chang GJ, Cormier JN. Advanced-stage colon cancer prior to the screening age: Association with age, race, and insurance status. American Society of Clinical Oncology Gastrointestinal Cancer Symposium (ASCO Merit Award), San Francisco, CA, 2011. e-Pub 2011.
61. Vu TM, You YN, Saraiya D, Lynch PM, Rodriguez-Bigas M. Patient-centered access to genetic counseling services. 4th Biennial Meeting International Society for Gastrointestinal Hereditary Tumors InSiGHT, San Antonio, TX, 2011. e-Pub 2011.
62. Jiang ZQ, Mehta TR, You YN, Chang GJ, Eng C, Overman MJ, Maru D, Hamilton SR, Kopetz S. Association of PTEN loss and local recurrence in stage II-III colon cancer. American Society of Clinical Oncology Gastrointestinal Cancer Symposium, San Francisco, CA, 2011. e-Pub 2011.
63. Hsu C, Rashid A, Xing Y, Chiang YJ, Chang GJ, You YN, Feig BW, Cormier JN. Histologic subtypes of neuroendocrine tumors of the appendix have varying malignant potential. Society of Surgical Oncology 64th Annual Cancer Symposium, San Antonio, TX, 2011. e-Pub 2011.
64. You YN, Vu T, Saraiya D, Lynch P, Rodriguez-Bigas MA. Routine prospective microsatellite instability testing for colorectal cancer: implementation of an institutional algorithm. 4th Biennial Meeting International Society for Gastrointestinal Hereditary Tumours InSiGHT, San Antonio, TX, 2011. e-Pub 2011.
65. You YN, Lynch PM, Bannon S, Taggart M, Reeves C, Modaro C, Fischer W, Rodriguez-Bigas M, Skibber J. Improving the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) syndrome among young colorectal cancer patients. The University of Texas System Clinical Safety and Effectiveness Conference: Building the Bridge: Excellence through Innovation, Education and Financial Stewardship, 2011. e-Pub 2011.
66. You YN, Xing Y, Feig BW, Rodriguez-Bigas M, Skibber JM, Chang GJ, Ling YK, Cormier JN. Risk factors for colorectal cancer in patients younger than 50. Association of American Surgery/Society of University Surgeons Annual Meeting, Huntington Beach, CA, 2011. e-Pub 2011.
67. Chagpar R, Cormier JN, Feig BW, Chang GJ, You YN, Rodriguez-Bigas MA, Skibber JM, Xing Y. Adherence to NCCN treatment guidelines for rectal cancer: Analysis of national practice patterns (ASCO Merit Award). American Society of Clinical Oncology Annual Meeting, Chicago, IL, 2011. e-Pub 2011.
68. You YN, Vu TM, Saraiya D, Lynch PM, Feig BW, Skibber JM, Chang GJ, Rodriguez-Bigas MA. Routine tumor microsatellite instability testing identifies Lynch syndrome on otherwise unsuspected patients with colorectal cancer. American Society of Colon and Rectal Surgeons Annual Meeting, Vancouver, Canada, 2011. e-Pub 2011.
69. Chagpar R, Xing Y, You YN, Chiang Y, Feig BW, Chang GJ, Cormier JN. Predicting adherence to stage-specific treatment guidelines for adenocarcinoma of the colon. Society of Surgical Oncology ‘s 64th Annual Cancer Symposium, San Antonio, TX, 2011. e-Pub 2011.
70. Kaur H, Ernst R, Sagebiel T, You YN, Hou P, Choi H. Preoperative staging of primary rectal tumors: role of thin section multiplanar 2 D T2 FSE imaging, 3D cube, and diffusion-weighed imaging (Certificate of Merit). Radiological Society of North America 96th Annual Meeting, Chicago, IL, 2010. e-Pub 2010.
71. Ernst RD, Kaur H, You YN, Chang GJ, Rodriguez-Bigas MA, Choi H, Kirshner K, Tamm E. Structured reporting for MRI staging of rectal cancer. Radiological Society of North America 96th Annual Meeting, Chicago, IL, 2010. e-Pub 2010.
72. Faria S, Sagebiel T, You YN, Balachandran A, Sacks J, Bhosale P. Omental and muscle flaps for reconstruction following abdominoperineal resection and pelvic exenteration: applications, postsurgical anatomy, and radiologic appearance. Radiological Society of North America 96th Annual Meeting, Chicago, IL, 2010. e-Pub 2010.
73. Saraiya D, You YN, Askew RL, Vu TM, Lynch PM, Rodriguez-Bigas M. The importance of tumor studies in the initial evaluation for Lynch Syndrome: a comparison of MMR positive and negative patients. Collaborative Group of the Americas on Colorectal Cancer 14th Annual Meeting, Dallas, Texas, 2010. e-Pub 2010.
74. You YN, Saraiya D, Vu TM, Veerapong J, Lynch PM, Rodriguez-Bigas MA. Rectal cancer in patients with hereditary nonpolyposis colorectal cancer: Surgical management and survival outcomes. Collaborative Group of the Americas on Colorectal Cancer 14th Annual Meeting, Dallas, TX, 2010. e-Pub 2010.
75. You YN, Habiba H, Chang GJ, Rodriguez-Bigas MA, Skibber JM. Prognostic value of pain and quality of life in patients with locally recurrent rectal cancer. Society of Surgical Oncology 63rd Annual Meeting, St. Louis, MO, 2010. e-Pub 2010.
76. Zafar SN, Hu CY, Snyder RA, Cuddy A, You YN, Lowenstein LM, Volk RJ, Chang GJ. Predicting Risk of Recurrence after Colorectal Cancer Surgery in the United States: An Analysis of a Special Commission on Cancer National Study.

Book Chapters

1. Weiser R, You YN. Surgical Principles. In: Gunderson and Tepper's Clinical Radiation Oncology. 6th. Elsevier, 2025.
2. Snyder, RA, Dasari, NV, You, YN. Liquid Biopsy. In: Colorectal Liver Metastasis. 1st. Springer, 457-464, 2022.
3. You YN, Zafar S, Bednarski B. Robotic abdominal perineal resection. In: Techniques in Minimally Invasive Surgery. Springer, 2021.
4. Day R, You YN. Surgical Principles. In: Gunderson & Tepper's Clinical Radiation Oncology. 5th. Elsevier, 2020.
5. Marcente M, George TJ, You YN. Lynch Syndrome: Management of Rectum—What Operation?. In: Management of Hereditary Colorectal Cancer: A Multidisciplinary Approach. Springer, 2020.
6. Quezada-Diaz F, Sammour T, Smith JJ, You YN. Watch and Wait in Rectal Cancer Patients with Clinical Complete Response to Neoadjuvant Therapy, the American Viewpoint. In: Comprehensive Rectal Cancer Care. Springer, 2019.
7. Hassan I, You YN. Quality of life after multidisciplinary management of rectal cancer. In: Rectal cancer. Springer, 2018.
8. You YN, Kalady M. Hereditary Colorectal Cancer Syndromes. In: The American Society of Colorectal Surgeons Textbook of Colorectal Surgery. Springer, 2016.
9. You YN, Donohue JH. Surgical Principles. In: Gunderson & Tepper's Clinical Radiation Oncology. 4th. Elsevier, 2016.
10. Bailey CE, Vilar Sanchez E, You YN. Adjuvant and neoadjuvant management of cancer of the colon and rectum. In: American College of Surgeons Textbook of Surgery. 6th. Decker Intellectual Properties, Inc, 6-14, 2014.
11. You YN. Transverse colectomy: Open technique. In: Operative Techniques in Surgery. Wolters Kluwer Health/Lippincott Williams & Wilkens, 1017-1024, 2014.
12. You YN, Donohue JH, Nagorney DM. Splenectomy for Conditions Other Than Trauma. In: Shackelford's Surgery of the Alimentary Tract. 7th. Elsevier Saunders, 1659-78, 2013.
13. You YN, Donohue JH. Surgical Principles. In: Clinical Radiation Oncology. 3rd. Elsevier, 153-163, 2012.
14. You YN, Wolff BG. Surgery for the Polyposis Syndrome. In: Current Surgical Therapy. 10th. Elsevier, 181-185, 2011.
15. Silberfein EJ, Chang GJ, You YN, Feig BW. Cancer of the Colon, Rectum, and Anus. In: The MD Anderson Surgical Oncology Handbook. 5th. Wolters Kluwer Health/Lippincott Williams & Wilkins, 347-415, 2011.
16. You YN, Nelson H. Surgery: Local Excision. In: Rectal Cancer: International Perspectives on Multimodality Treatment. Humana, 37-51, 2009.
17. You YN, Lakhani V, Wells SA. The Multiple Endocrine Neoplasia Syndromes. In: Genomic and Personalized Medicine. Academic, 931-44, 2009.
18. You YN, Donohue JH, Nagorney DM. Splenectomy For Conditions Other Than Trauma. In: Shackelford's Surgery of the Alimentary Tract. 6th. Elsevier Saunders, 1822-41, 2007.
19. You YN, DeMatteo RP. Gastrointestinal Stromal Tumor: Surgery. In: Gastrointestinal Oncology: Evidence and Analysis. Informa Healthcare, 337-350, 2007.

Letters to the Editor

1. Maki H, Vauthey JN, You YN. Reply to: Critical Appraisal of multidisciplinary treatment outcomes in young-onset colorectal cancer with synchronous liver metastases: A retrospective analysis and methodological Considerations. Eur J Surg Oncol: 108520.
2. Mork ME, You YN, Vilar E. Reply to L.B. Saltz. J Clin Oncol 34: 1560-1, 2016.
3. You YN. Risk factors for young-onset advanced colorectal cancer-reply. Arch Intern Med 172: 971-2, 2012.